Professor Gareth Evans MD FCRP

Photograph of Gareth Evans

Professor of Medical Genetics and Cancer Epidemiology

Genomic Medicine,

Manchester Academic Health Science Centre,

The University of Manchester,

Central Manchester University Hospitals NHS Foundation Trust,

Saint Mary's Hospital, Oxford Road, Manchester M13 9WL, UK


Professor of Medical Genetics and Cancer Epidemiology, The University of Manchester

Consultant in Medical Genetics and Cancer Epidemiology, Central Manchester Hospitals NHS Foundation Trust and The Christie NHS Foundation Trust

Memberships of Committees and Professional Bodies

Member and Ex Council Member of the Clinical Genetics Society

Member and Ex Chairman of the Cancer Genetics Group

Member and ex Council Member of the British Society of Genomic Medicine

Member European Society of Human Genetics



1. a) Medical student clinical course teaching (full year seminars). Medical student options two per year, 3 in 1995.

    b) MSc in genetic counselling

    c) teaching of registrar/SR grades internally + lectures to SHO and registrars in paediatrics and obstetrics.

    d) Postgraduate lectures throughout region.

    e) Postgraduate education representative of department.

2. a) FRCR in clinical oncology seminars - Christie hospital

     b) MSc in medical oncology seminars - Christie hospital

     c) MSc in cancer genetics - Royal Marsden hospital.

3. Devised and supervise Breast Cancer Genetics Training course for breast care nurses and clinicians. Approved by Director of Cancer Services (Region) and School of Nursing.


Social Responsibility

Director Nannerch Players

Trustee Breast Cancer Now

Trustee Neuro Foundation

Trustee Hereditary Breast Cancer Helpline

Advisor The Gorlin Group Scientific Advisor Genesis Breast Cancer Prevention Appeal


Professor Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West Region of England, which is nationally regarded. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and is now clinical lead (2011-). He lectures throughout the UK and internationally on hereditary breast cancer and cancer syndromes. He has given plenary lectures at many international meetings including the International Congress of Human Genetics and two invited lecture tours across Australia (1995, 2001). He has developed a national training program for clinicians, nurses and genetic counsellors in breast cancer genetics and established a system for risk assessment and counselling for breast cancer in Calman breast units implemented through a training course (1998-2011).


He has published 628 peer reviewed research publications; 240 as first or senior author. He has published over 90 reviews and chapters and has had a book published by Oxford University Press on familial cancer. He has an ISI web of knowledge H-index of 86 and a google scholar H-index of 113 having only published his first article in 1990. In the last 5 years he has raised over £10 million in grants for multicentre and local studies – approximately £5 million to Manchester. He is Chief Investigator on a £1.59 million NIHR program grant (2009-2014 and 2016-2020) on breast cancer risk prediction and also has an NIHR RfPB grant as CI (2011).  He has led a successful bid for a Nationally funded NF2 service (£7.5 million pa) that started in 2010 and is involved in the national complex NF1 service.

Research interests

  • inherited breast and ovarian cancer and its imaging
  • Neurofibromatosis types 1 and 2 and imaging
  • Other inherited tumour predispositions




Collaborators and affiliated staff

Dr Miriam Smith

Helen Byers

Dr Elaine Harkness

Prof William Newman

Prof Tony Howell



  • Basu, N. N., Littlechild, S., Barr, L., Ross, G. L., & Evans, D. G. (2016). Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.Annals of the Royal College of Surgeons of England. DOI:10.1308/rcsann.2016.0039. Publication link: 77df67d7-541e-4536-8072-a90691392e13 | PubMed:26741657
  • Byers, H., Yvonne Wallis, Van Veen, E., Lalloo, F., Kim Reay, Smith, P., ... Evans, D. (2016). Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing. European Journal of Human Genetics. DOI:10.1038/ejhg.2016.57. Publication link: 6026d56d-e76d-4f4c-a689-359afc62a0a7
  • Evans, D. G. R., Donnelly, L. S., Harkness, E. F., Astley, S. M., Stavrinos, P., Dawe, S., ... Howell, A. (2016). Breast cancer risk feedback to women in the UK NHS breast screening population. British Journal of Cancer, 114(9), 1045-52. DOI:10.1038/bjc.2016.56. Publication link: d9d2427d-9385-498f-a704-08dbeabe2e24 | PubMed:27022688
  • Evans, G., Kotre, C. J., Harkness, E., Wilson, M., Maxwell, A., & Howell, A. (2016). No strong evidence for increased risk of breast cancer 8 to 26 years after multiple mammograms in their thirties in women at moderate and high familial risk.The British journal of radiology. DOI:10.1259/bjr.20150960. Publication link: 63b65d89-67ce-47cc-bb6c-8adea05a5abd | PubMed:26795734
  • Gerkes, E. H., Fock, J. M., den Dunnen, W. F. A., van Belzen, M. J., van der Lans, C. A., Hoving, E. W., ... Olderode-Berends, M. J. W. (2016). A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.Neurogenetics, 17(2), 83-89. DOI:10.1007/s10048-015-0472-y. Publication link: 776a6bf2-e6ae-473d-ab72-feab00e5746a | PubMed:26803492
  • Harvie, M., Sims, A., Pegington, M., Spence, K., Mitchell, A., Vaughan, A. A., ... Howell, A. (2016). Intermittent energy restriction induces changes in breast gene expression and systemic metabolism. Breast Cancer Research. . Publication link: bc215581-3d0c-4b7e-9a42-15bdba143cd4
  • Møller, P., Seppälä, T., Bernstein, I., Holinski-Feder, E., Sala, P., Evans, G., ... Capella, G. (2016). Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: A report from the prospective Lynch syndrome database. Gut. DOI:10.1136/gutjnl-2016-311403. Publication link: 527bfb1f-cbea-450b-9a0d-270cc55088c5


  • Amin Al Olama, A., Dadaev, T., Hazelett, D. J., Li, Q., Leongamornlert, D., Saunders, E. J., ... Tidball, S. (2015). Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.Human molecular genetics, 24(19). DOI:10.1093/hmg/ddv203. Publication link: 32c92a34-21ed-4442-bbb3-cdddf381d813 | PubMed:26025378
  • Barrow, P., Green, K., Clancy, T., Lalloo, F., Hill, J., & Evans, D. G. (2015). Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey.Clinical Genetics. DOI:10.1111/cge.12559. Publication link: f75effef-6ffa-428d-857d-1adf88e744b4 | PubMed:25652327
  • Basu, N. N., Barr, L., Ross, G. L., & Evans, D. G. (2015). Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.International journal of surgical oncology, 2015. DOI:10.1155/2015/901046. Publication link: 2b0f2677-8bc1-4edc-8f79-87f5d548f2e8 | PubMed:25692038
  • Basu, N. N., Ingham, S., Hodson, J., Lalloo, F., Bulman, M., Howell, A., & Evans, D. G. (2015). Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.Familial Cancer, 14(4). DOI:10.1007/s10689-015-9825-9. Publication link: 7abc7f4c-21c1-4fbf-a740-eff91a7c5ed5 | PubMed:26239694
  • Basu, N. N., Ross, G. L., Evans, D. G., & Barr, L. (2015). The Manchester guidelines for contralateral risk-reducing mastectomy.World journal of surgical oncology, 13. DOI:10.1186/s12957-015-0638-y. Publication link: cfbb5eaf-b5d8-48ea-8a45-0164670e539b | PubMed:26245209
  • Blein, S., Bardel, C., Danjean, V., McGuffog, L., Healey, S., Barrowdale, D., ... Cox, D. G. (2015). An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.Breast cancer research : BCR, 17. DOI:10.1186/s13058-015-0567-2. Publication link: 1d10c257-026d-4e6a-af82-0be0eb51cb43 | PubMed:25925750
  • Brentnall, A. R., Harkness, E. F., Astley, S. M., Donnelly, L. S., Stavrinos, P., Sampson, S., ... Dawe, S. (2015). Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Research (Online), 17(147), 1-10. DOI:10.1186/s13058-015-0653-5. Publication link: 65c2ccc8-5073-4cf9-b1dc-6081d62940c1 | PubMed:26627479
  • Chandrasekaran, D., Menon, U., Evans, G., Crawford, R., Saridogan, E., Jacobs, C., ... Manchanda, R. (2015). Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK.Familial Cancer, 14(4). DOI:10.1007/s10689-015-9823-y. Publication link: 288550d7-b7a7-49de-8bce-a9f5b2aae4a4 | PubMed:26178205
  • Cremers, R. G., Eeles, R. A., Bancroft, E. K., Ringelberg-Borsboom, J., Vasen, H. F., Van Asperen, C. J., ... Wilson, P. (2015). The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers.Urologic oncology, 33(5). DOI:10.1016/j.urolonc.2015.01.018. Publication link: c5cc6deb-bf5c-4095-8f94-979603402fe9 | PubMed:25746941
  • Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., ... Foulkes, W. D. (2015). Gene-panel sequencing and the prediction of breast-cancer risk.The New England journal of medicine, 372(23). DOI:10.1056/NEJMsr1501341. Publication link: 89adb5b7-3df5-46ea-854e-c5fa7d3da598 | PubMed:26014596
  • Eccles, B. K., Copson, E. R., Cutress, R. I., Maishman, T., Gerty, S. M., Durcan, L., ... Lakhani, S. (2015). Family history and outcome of young patients with breast cancer in the UK (POSH study).The British journal of surgery, 102(8). DOI:10.1002/bjs.9816. Publication link: abececf3-4c0a-41db-8a2a-cc4ab52b5d06 | PubMed:25989914
  • Eccles, D. M., Li, N., Handwerker, R., Maishman, T., Copson, E. R., Durcan, L. T., ... Campbell, I. (2015). Genetic testing in a cohort of young patients with HER2-amplified breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. DOI:10.1093/annonc/mdv592. Publication link: b923b7f9-d682-4a27-9fc0-4d015f8d92ce | PubMed:26681682
  • Evans, D. G. R. (2015). Neurofibromatosis type 2.Handbook of Clinical Neurology, 132. DOI:10.1016/B978-0-444-62702-5.00005-6. Publication link: 278cf9c2-cbff-4dde-830d-5465edbcff61 | PubMed:26564072
  • Evans, D. G., & Howell, A. (2015). Can the breast screening appointment be used to provide risk assessment and prevention advice?. Breast cancer research : BCR, 17. DOI:10.1186/s13058-015-0595-y. Publication link: ca97e7f2-d11e-41a5-a2cc-603c8a549784 | PubMed:26155950
  • Evans, D. G., & Maxwell, A. (2015). MRI Screening in Women With a Personal History of Breast cancer.Unknown Journal, 108(3). . Publication link: 7efe3f5e-051d-4daa-954e-f4534ee14b4c
  • Evans, D. G., Freeman, S., Gokhale, C., Wallace, A., Lloyd, S. K., Axon, P., ... Ramsden, R. T. (2015). Bilateral vestibular schwannomas in older patients: NF2 or chance?. Journal of medical genetics. DOI:10.1136/jmedgenet-2014-102973. Publication link: b395d143-d6cb-4dad-9d42-7e87eb9972ea | PubMed:25725045
  • Evans, D. G., Wisely, J., Clancy, T., Lalloo, F., Wilson, M., Johnson, R., ... Howell, A. (2015). Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women.Breast cancer research : BCR, 17(1). DOI:10.1186/s13058-015-0650-8. Publication link: aafdfb8b-4b5f-46c5-b5b4-652fb1a6ac63 | PubMed:26603733
  • Evans, G., Tyrer, J., Shen, H. C., Lawrenson, K., Lee, J. M., Spindler, T. J., ... Visvader, J. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer.Nature Genetics, 47(2). DOI:10.1038/ng.3185. Publication link: 93998625-ab14-4241-91ed-86c5c3f8d1f2 | PubMed:25581431
  • Evans, L. T., Van Hoff, J., Hickey, W. F., Smith, M. J., Evans, G., Newman, W. G., & Bauer, D. F. (2015). SMARCE1 mutations in pediatric clear cell meningioma: case report.Journal of neurosurgery. Pediatrics, 16(3). DOI:10.3171/2015.3.PEDS14417. Publication link: 87785671-a670-4893-9b15-2bcaa94402f1 | PubMed:26114992
  • Guo, Q., Schmidt, M. K., Kraft, P., Canisius, S., Chen, C., Khan, S., ... Pharoah, P. D. P. (2015). Identification of novel genetic markers of breast cancer survival.Journal of the National Cancer Institute, 107(5). DOI:10.1093/jnci/djv081. Publication link: bbbc47a0-f1a0-4358-aad4-b23efc5ca42f | PubMed:25890600
  • Harkness, E. F., Barrow, E., Newton, K., Green, K., Clancy, T., Lalloo, F., ... Evans, D. G. (2015). Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.Journal of medical genetics, 52(8). DOI:10.1136/jmedgenet-2015-103216. Publication link: 800bdbed-6451-4714-92d2-85592ed448c5 | PubMed:26101330
  • Harvie, M., Howell, A., & Evans, D. G. (2015). Can diet and lifestyle prevent breast cancer: what is the evidence?. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting, 35. DOI:10.14694/EdBook_AM.2015.35.e66. Publication link: cfaa835c-0a83-43d5-889a-55c51f2d6dd9 | PubMed:25993238
  • Heineman, T. E., Evans, D. G. R., Campagne, F., & Selesnick, S. H. (2015). In Silico Analysis of NF2 Gene Missense Mutations in Neurofibromatosis Type 2: From Genotype to Phenotype.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 36(5). DOI:10.1097/MAO.0000000000000639. Publication link: 03823e5e-3041-466a-9baa-99173fff3426 | PubMed:25931164
  • Higgs, J. E., Harkness, E. F., Bowers, N. L., Howard, E., Wallace, A. J., Lalloo, F., ... Evans, D. G. (2015). The BRCA2 polymorphic stop codon: stuff or nonsense?. Journal of medical genetics, 52(9). DOI:10.1136/jmedgenet-2015-103206. Publication link: 377809bb-77b7-42ec-9f36-47514b1df291 | PubMed:26041759
  • Julian-Reynier, C., Bouhnik, A-D., Evans, D. G., Harris, H., van Asperen, C. J., Tibben, A., ... Nippert, I. (2015). General Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles.BMC Cancer, 15(1). DOI:10.1186/s12885-015-1281-2. Publication link: 71db4bc5-d5bd-4743-bd05-98f7b68ff316 | PubMed:25886583
  • Kotsopoulos, J., Lubinski, J., Gronwald, J., Cybulski, C., Demsky, R., Neuhausen, S. L., ... Little, J. (2015). Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.International journal of cancer. Journal international du cancer, 137(5). DOI:10.1002/ijc.29386. Publication link: 34923893-3096-42d6-875f-06a98fa81a63 | PubMed:25482078
  • Maishman, T., Copson, E., Stanton, L., Gerty, S., Dicks, E., Durcan, L., ... Lakhani, S. (2015). An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.British Journal of Cancer, 112(6). DOI:10.1038/bjc.2015.57. Publication link: 372a81e7-ef4a-4efd-8a4e-48eb0c3a4378 | PubMed:25675148
  • Mccabe, M., Li, K-L., Djoukhadar, I., Zhu, X., Zhao, S., Lloyd, S., ... Jackson, A. (2015). Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.Neuro-oncology, 18(2), 275-282. DOI:10.1093/neuonc/nov168. Publication link: 16b9d333-730a-426c-88e5-9c879625d3c3 | PubMed:26311690
  • Møller, P., Seppälä, T., Bernstein, I., Holinski-Feder, E., Sala, P., Evans, D. G., ... Möslein, G. (2015). Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.Gut. DOI:10.1136/gutjnl-2015-309675. Publication link: ff50f94f-549b-41df-90e8-ad7af298e250 | PubMed:26657901
  • Møller, P., Tharmaratnam, K., Howell, A., Stavrinos, P., Sampson, S., Wallace, A., ... Evans, D. G. (2015). Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.Breast Cancer Research and Treatment, 152(1), 87-94. DOI:10.1007/s10549-015-3448-6. Publication link: d5b80d66-bef0-48f7-b5a1-d3b6aefd8890 | PubMed:26037256
  • Movahedi, M., Bishop, D. T., Macrae, F., Mecklin, J-P., Moeslein, G., Olschwang, S., ... Mathers, J. C. (2015). Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(31). DOI:10.1200/JCO.2014.58.9952. Publication link: 3c31f91d-3773-42f7-91bf-df686ac87c3d | PubMed:26282643
  • Newton, K., Green, K., Lalloo, F., Evans, D. G., & Hill, J. (2015). Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 17(1). DOI:10.1111/codi.12778. Publication link: 0d71c1df-d3a1-46cd-b61b-f2c18f132dbd | PubMed:25213040
  • Peterlongo, P., Chang-Claude, J., Moysich, K. B., Rudolph, A., Schmutzler, R. K., Simard, J., ... Borg, A. (2015). Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 24(1). DOI:10.1158/1055-9965.EPI-14-0532. Publication link: d9b2bccd-b689-4d21-97d5-8a86c4921ca3 | PubMed:25336561
  • Pirie, A., Guo, Q., Kraft, P., Canisius, S., Eccles, D. M., Rahman, N., ... Schmidt, M. K. (2015). Common germline polymorphisms associated with breast cancer-specific survival.Breast cancer research : BCR, 17. DOI:10.1186/s13058-015-0570-7. Publication link: a73727d9-9aab-41a2-959d-11b6bf2ffd82 | PubMed:25897948
  • Raffalli-Ebezant, H., Rutherford, S. A., Stivaros, S., Kelsey, A., Smith, M., Evans, D. G., & Kilday, J-P. (2015). Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 31(3), 441-447. DOI:10.1007/s00381-014-2558-5. Publication link: 97f2464c-b35a-4789-8db1-2534eeaaaa96 | PubMed:25249420
  • Rebbeck, T. R., Mitra, N., Wan, F., Sinilnikova, O. M., Healey, S., McGuffog, L., ... Andrulis, I. (2015). Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.JAMA, 313(13). DOI:10.1001/jama.2014.5985. Publication link: 7883f855-c5db-42b2-abef-dd69eb56e21a | PubMed:25849179
  • Ruggieri, M., Praticò, A. D., & Evans, D. G. (2015). Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.Seminars in pediatric neurology, 22(4). DOI:10.1016/j.spen.2015.10.008. Publication link: e2d82a5f-9573-4f44-b3e9-5d0806bdd3f7 | PubMed:26706012
  • Sahasrabudhe, R., Estrada, A., Lott, P., Martin, L., Polanco Echeverry, G., Velez, A., ... Lowery, A. J. (2015). The 8q24 rs6983267G variant is associated with increased thyroid cancer risk.Endocrine-related cancer, 22(5). DOI:10.1530/ERC-15-0081. Publication link: 0af29340-c12b-4b52-b006-40693de81e19 | PubMed:26290501
  • Sestak, I., Holli, K., Forbes, J. F., Abdi, E., Anderson, E., Atkinson, C., ... Cawthorne, S. (2015). Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.The Lancet. Oncology, 16(1), 67-75. DOI:10.1016/S1470-2045(14)71171-4. Publication link: 856d3422-5b03-4373-96dc-d33ef6516213 | PubMed:25497694
  • Smith, M. J., Hexter, A., Jones, A., Joe, H., Heap, L., Wallace, A. J., ... Wilson, S. (2015). Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients.Journal of Medical Genetics, 52(10), 699-705. DOI:10.1136/jmedgenet-2015-103290. Publication link: 0110b0cc-bd7e-4e40-8858-1f06ddd10e81 | PubMed:26275417
  • Smith, M. J., Urquhart, J. E., Harkness, E. F., Miles, E. K., Bowers, N. L., Byers, H. J., ... Evans, D. G. (2015). The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes.Human Mutation. DOI:10.1002/humu.22938. Publication link: de92b090-e390-49d1-8a5c-1cebd0ed3b53 | PubMed:26615784
  • Smith, M., Isidor, B., Beetz, C., Williams, S. G., Bhaskar, S. S., Richer, W., ... Evans, G. (2015). Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis. Neurology, 84(2), 141-147. DOI:10.1212/WNL.0000000000001129. Publication link: a284d8f5-b965-4138-938c-b0ab83e8bb7b | PubMed:25480913
  • Stivaros, S. M., Stemmer-Rachamimov, A. O., Alston, R., Plotkin, S. R., Nadol, J. B., Quesnel, A., ... Evans, D. G. (2015). Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.Journal of medical genetics, 52(8). DOI:10.1136/jmedgenet-2015-103050. Publication link: 37150775-6212-4ec3-9e90-e658401aea3c | PubMed:26104281
  • Wright, C. E., Harvie, M., Howell, A., Evans, D. G., Hulbert-Williams, N., & Donnelly, L. S. (2015). Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention.Hereditary cancer in clinical practice, 13(1). DOI:10.1186/s13053-014-0023-9. Publication link: 1659a53f-1c5e-4d20-9417-9edb4cf66dab | PubMed:25648828


  • Bancroft, E. K., Page, E. C., Castro, E., Lilja, H., Vickers, A., Sjoberg, D., ... Eeles, R. A. (2014). Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study. European Urology, 66(3), 489-499. DOI:10.1016/j.eururo.2014.01.003. Publication link: f7d3cfc9-3ada-4371-9f94-bd36953530d0 | PubMed:24484606
  • Birch, J., Meyer, S., Tischkowitz, M., Chandler, K., Gillespie, A., Birch, J. M., & Evans, D. G. (2014). Fanconi anaemia, BRCA2 mutations and childhood cancer: A developmental perspective from clinical and epidemiological observations with implications for genetic counselling. Journal of Medical Genetics, 51(2), 71-75. DOI:10.1136/jmedgenet-2013-101642. Publication link: 13e5ddb9-8228-42ce-8f3d-85c72f247c62 | PubMed:24259538
  • Blakeley, J., Schreck, K. C., Evans, D. G., Korf, B. R., Zagzag, D., Karajannis, M. A., ... Belzberg, A. J. (2014). Clinical response to bevacizumab in schwannomatosis.Neurology. DOI:10.1212/WNL.0000000000000997. Publication link: 254420bb-eec9-4d4f-baa7-e095b35bddfb | PubMed:25339217
  • Brentnall, A. R., Evans, D. G., & Cuzick, J. (2014). Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK. British Journal of Cancer, 110(3), 827-828. DOI:10.1038/bjc.2013.747. Publication link: 2f8812f2-7470-424a-9726-2b3cfe2cc028
  • Castro, E., Goh, C., Leongamornlert, D., Saunders, E., Tymrakiewicz, M., Dadaev, T., ... Eeles, R. (2014). Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.European urology. DOI:10.1016/j.eururo.2014.10.022. Publication link: a892e04f-3e4c-499d-bed2-5ef8c48f1cd1 | PubMed:25454609
  • Chai, X., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., Isaacs, C., ... Rebbeck, T. R. (2014). Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. DOI:10.1007/s10549-014-3134-0. Publication link: 386f49df-bf14-4b79-b159-080cbbfa713c | PubMed:25311111
  • Donnelly, L. S., Evans, D. G., Wiseman, J., Fox, J., Greenhalgh, R., Affen, J., ... Howell, A. (2014). Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic. British Journal of Cancer, 110(7), 1681-1687. DOI:10.1038/bjc.2014.109. Publication link: 060dc9c5-b7cb-4289-9a99-f6ba8c23c03a | PubMed:24594998
  • Evans, D. G. (2014). BCRT response to Moller.Breast Cancer Research and Treatment, 148(3). DOI:10.1007/s10549-014-3200-7. Publication link: b22f5b0e-2008-448b-b384-fad05f2bd270 | PubMed:25398654
  • Evans, D. G., & Stivaros, S. (2014). Multifocality in neurofibromatosis type 2.Neurogenetics. . Publication link: 11eaa0f5-7a07-4a6c-b886-2196c2033792
  • Evans, D. G., Barwell, J., Eccles, D. M., Collins, A., Izatt, L., Jacobs, C., ... Wallace, A. (2014). The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.Breast cancer research : BCR, 16(5). DOI:10.1186/s13058-014-0442-6. Publication link: 53b09bfd-45df-4461-93aa-efc8d7a86423 | PubMed:25510853
  • Evans, D. G., Brentnall, A. R., Harvie, M., Dawe, S., Sergeant, J. C., Stavrinos, P., ... Howell, A. (2014). Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.Cancer Prevention Research, 7(10), 993-1001. DOI:10.1158/1940-6207.CAPR-14-0037. Publication link: ff65e569-4f8e-4f2f-8158-52f718b196c7 | PubMed:25047362
  • Evans, D. G., Harkness, E., Lalloo, F., & Howell, A. (2014). Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.Journal of medical genetics, 51(9). DOI:10.1136/jmedgenet-2014-102336. Publication link: d5201de1-2e12-40d9-b940-53077e7e71cf | PubMed:25053764
  • Evans, G., Armstrong, A. C., & Evans, G. D. (2014). Management of women at high risk of breast cancer. BMJ, 348, [g2756]. DOI:10.1136/bmj.g2756. Publication link: e398650f-3e17-456c-ac6a-0b2dcec2cc3f | PubMed:24778341
  • Evans, G., Copson, E., Maishman, T., Gerty, S., Eccles, B., Stanton, L., ... Eccles, D. (2014). Ethnicity and outcome of young breast cancer patients in the United Kingdom: The POSH study. British Journal of Cancer, 110(1), 230-241. DOI:10.1038/bjc.2013.650. Publication link: 252f699f-e02c-49e4-b203-709938966fba | PubMed:24149174
  • Evans, G., Evans, D. G. R., Ingham, S., Dawe, S., Roberts, L., Lalloo, F., ... Howell, A. (2014). Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme. Familial Cancer, 13(2), 189-196. DOI:10.1007/s10689-013-9694-z. Publication link: a7276434-443e-404c-93c1-e0e19ce4218c | PubMed:24276527
  • Evans, G., Evans, D. G., Thomas, S., Caunt, J., Roberts, L., Howell, A., ... Audisio, R. (2014). Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02). Familial Cancer, 13(1), 13-21. DOI:10.1007/s10689-013-9661-8. Publication link: c1419dab-4bd9-4f5f-a8ee-8622ec4a559d | PubMed:23733252
  • Evans, G., Ferner, R. E., Shaw, A., Evans, D. G., McAleer, D., Halliday, D., ... Golding, J. F. (2014). Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. Journal of Neurology, 261(5), 963-969. DOI:10.1007/s00415-014-7303-1. Publication link: 3e255087-eef9-4e6e-b04f-39c3b3c29cd1 | PubMed:24619350
  • Evans, G., Gareth, E. D., Nisha, K., Yit, L., Soujanye, G., Emma, H., ... Scurr, E. (2014). MRI breast screening in high-risk women: Cancer detection and survival analysis. Breast Cancer Research and Treatment, 145(3), 663-672. DOI:10.1007/s10549-014-2931-9. Publication link: e9fecd5e-2be3-484d-a51c-6aed679bbc2c | PubMed:24687378
  • Evans, G., Killick, E., Tymrakiewicz, M., Cieza-Borrella, C., Smith, P., Thompson, D. J., ... Eeles, R. A. (2014). Telomere length shows no association with BRCA1 and BRCA2 mutation status. PLoS ONE, 9(1), [e86659]. DOI:10.1371/journal.pone.0086659. Publication link: eedcb171-6c83-4757-be92-6ed4f8bc409a | PubMed:24489760
  • Evans, G., Kotsopoulos, J., Lubinski, J., Moller, P., Lynch, H. T., Singer, C. F., ... Narod, S. A. (2014). Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Research and Treatment, 143(3), 579-586. DOI:10.1007/s10549-013-2823-4. Publication link: 5b88e180-9960-4f63-bb3b-8dd89bec2c5e | PubMed:24458845
  • Evans, G., Prosperi, M. C. F., Ingham, S. L., Howell, A., Lalloo, F., Buchan, I. E., & Evans, D. G. (2014). Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?. BMC Medical Informatics and Decision Making, 14(1), [87]. DOI:10.1186/1472-6947-14-87. Publication link: 639f5f9c-ae0f-49ed-8f91-98174affa6c9 | PubMed:25274085
  • Garg, S., Plasschaert, E., Descheemaeker, M-J., Huson, S., Borghgraef, M., Vogels, A., ... Green, J. (2014). Autism Spectrum Disorder Profile in Neurofibromatosis Type I.Journal of Autism and Developmental Disorders, 45(6). DOI:10.1007/s10803-014-2321-5. Publication link: 15c35e87-092c-4695-a9cc-8085a59b0b13 | PubMed:25475362
  • Gilkes, C. E., & Evans, D. G. (2014). Review of radiation therapy services for neurofibromatosis (NF2) patients in England. British Journal of Neurosurgery, 28(1), 16-19. DOI:10.3109/02688697.2013.861386. Publication link: 5eb2279b-a197-4161-abd0-f6fc6c7b74a0 | PubMed:24350733
  • Gronwald, J., Robidoux, A., Kim-Sing, C., Tung, N., Lynch, H. T., Foulkes, W. D., ... Fallen, T. (2014). Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment, 146(2), 421-427. DOI:10.1007/s10549-014-3026-3. Publication link: acaa86dc-cc32-47ac-a6ee-6fe15c1173c3 | PubMed:24951267
  • Howell, A., Anderson, A. S., Clarke, R., Duffy, S. W., Evans, G., Garcia-Closas, M., ... Harvie, M. (2014). Risk Determination and Prevention of Breast Cancer. Breast Cancer Research (Print), 16(5), 446. DOI:10.1186/s13058-014-0446-2. Publication link: 639310e8-4aea-4427-b3fe-369f78beaa8e | PubMed:25467785
  • Knappskog, S., Gansmo, L. B., Dibirova, K., Metspalu, A., Cybulski, C., Peterlongo, P., ... Lønning, P. E. (2014). Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649).Oncotarget, 5(18). . Publication link: 48afcaf2-aabc-44ab-893b-7667310593b7 | PubMed:25327560
  • Lloyd, S. K. W., Glynn, F. J., Rutherford, S. A., King, A. T., Mawman, D. J., O'Driscoll, M. P., ... Freeman, S. R. M. (2014). Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otology and Neurotology, 35(1), 43-51. DOI:10.1097/MAO.0000000000000185. Publication link: fc0c022b-b7c3-45e8-ae42-cdf7195860aa | PubMed:24335931
  • Mccabe, M., Smith, M. J., Beetz, C., Williams, S. G., Bhaskar, S. S., O'Sullivan, J., ... Evans, D. G. R. (2014). Germline Mutations in SUFU Cause Gorlin Syndrome-Associated Childhood Medulloblastoma and Redefine the Risk Associated With PTCH1 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(36). DOI:10.1200/JCO.2014.58.2569. Publication link: b08caf52-07fc-454b-b8ba-f90090a541b1 | PubMed:25403219
  • Mesher, D., Dove-Edwin, I., Sasieni, P., Vasen, H., Bernstein, I., Royer-Pokora, B., ... Thomas, H. (2014). A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer. International Journal of Cancer, 134(4), 939-947. DOI:10.1002/ijc.28397. Publication link: 3f1c4b6e-907e-424e-ab9a-0489aa033528 | PubMed:23901040
  • Newton, K., Jorgensen, N. M., Wallace, A. J., Buchanan, D. D., Lalloo, F., McMahon, R. F. T., ... Evans, D. G. (2014). Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC).Journal of medical genetics, 51(12), 789-796. DOI:10.1136/jmedgenet-2014-102552. Publication link: ad53bfbb-6da5-444a-87aa-7c3b4ceda619 | PubMed:25280751
  • Nieuwenhuis, M. H., Kets, C. M., Murphy-Ryan, M., Yntema, H. G., Evans, D. G., Colas, C., ... Vasen, H. F. A. (2014). Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome. Familial Cancer, 13(1), 57-63. DOI:10.1007/s10689-013-9674-3. Publication link: 24c78087-33d7-4244-84ca-bf962ddc077c | PubMed:23934601
  • Nippert, I., Julian-Reynier, C., Harris, H., Evans, G., Van Asperen, C. J., Tibben, A., & Schmidtke, J. (2014). Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: General practitioners' and breast surgeons' current practice and preferred practice responsibilities. Journal of Community Genetics, 5(1), 69-79. DOI:10.1007/s12687-013-0173-x. Publication link: c94d07d0-02b5-472b-bd15-f4dd710d4c4e | PubMed:24297247
  • Osorio, A., Milne, R. L., Kuchenbaecker, K., Vaclová, T., Pita, G., Alonso, R., ... Benitez, J. (2014). DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. PLoS Genetics, 10(4), [e1004256]. DOI:10.1371/journal.pgen.1004256. Publication link: 4bdb4de0-069a-449a-b2e7-e5e49e0b7c4e | PubMed:24698998
  • Plotkin, S. R., Albers, A. C., Babovic-Vuksanovic, D., Blakeley, J. O., Breakefield, X. O., Dunn, C. M., ... Lloyd, A. C. (2014). Update from the 2013 international neurofibromatosis conference.American journal of medical genetics. Part A. DOI:10.1002/ajmg.a.36754. Publication link: 1710b616-3c1d-477a-91eb-69f4bcaf27d5 | PubMed:25255738
  • Pooley, K. A., McGuffog, L., Barrowdale, D., Frost, D., Ellis, S. D., Fineberg, E., ... Dunning, A. M. (2014). Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status. Cancer Epidemiology Biomarkers and Prevention, 23(6), 1018-1024. DOI:10.1158/1055-9965.EPI-13-0635-T. Publication link: 3db6d09e-d531-4727-8860-dd8d522ebbc0 | PubMed:24642354
  • Qureshi, N., O'Flynn, N., & Evans, G. (2014). Dealing with family history of breast cancer: Something new, something old. British Journal of General Practice, 64(618), 6-7. DOI:10.3399/bjgp14X676267. Publication link: 00233711-25ee-4125-a991-14170191641a
  • Rauen, K. A., Huson, S. M., Burkitt-Wright, E., Evans, D. G., Farschtschi, S., Ferner, R. E., ... Upadhyaya, M. (2014). Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenues.American journal of medical genetics. Part A. DOI:10.1002/ajmg.a.36793. Publication link: 51c06fa4-b21d-48ec-8320-4879d701611c | PubMed:25393061
  • Smith, M. J., Wallace, A. J., Bennett, C., Hasselblatt, M., Elert-Dobkowska, E., Evans, L. T., ... Evans, D. G. (2014). Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.The Journal of pathology. DOI:10.1002/path.4427. Publication link: 29204cfb-4164-4ce3-92e2-f31370513599 | PubMed:25143307
  • Smith, M. J., Wallace, A. J., Bowers, N. L., Eaton, H., & Evans, D. G. R. (2014). SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors. Cancer Genetics. DOI:10.1016/j.cancergen.2014.04.001. Publication link: 5e643acd-e7e1-4317-87c5-33818df6a260 | PubMed:24933152
  • Smith, M., Bholah, Z., Smith, M. J., Byers, H. J., Miles, E. K., Evans, D. G., & Newman, W. G. (2014). Intronic splicing mutations in PTCH1 cause Gorlin syndrome. Familial Cancer, 13(3), 477-480. DOI:10.1007/s10689-014-9712-9. Publication link: 1762f803-e570-4565-ad73-9d56349576f6 | PubMed:24659465
  • Whitworth, J., Hoffman, J., Chapman, C., Ong, K. R., Lalloo, F., Evans, D. G., & Maher, E. R. (2014). A clinical and genetic analysis of multiple primary cancer referrals to genetics services.European journal of human genetics : EJHG. DOI:10.1038/ejhg.2014.157. Publication link: 60e75ccf-9ae7-46ce-8708-1afb028344dc | PubMed:25248401
  • Widemann, B. C., Acosta, M. T., Ammoun, S., Belzberg, A. J., Bernards, A., Blakeley, J., ... Morrison, H. (2014). CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. American Journal of Medical Genetics, Part A, 164(3), 563-578. DOI:10.1002/ajmg.a.36312. Publication link: 4f1c4764-cbad-405e-b7a5-9903bce5c87e
  • Yasar, B., Byers, H. J., Smith, M. J., Lear, J., Oudit, D., Bholah, Z., ... Evans, D. G. (2014). Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome. European Journal of Human Genetics. DOI:10.1038/ejhg.2014.167. Publication link: 78ea8956-1d2f-4aba-8ac0-fb45c2ee6a9b | PubMed:25159867


  • Barrow, E., Newton, K., Rajashanker, B., Lee, S., Evans, D. G., & Hill, J. (2013). Successful radiofrequency ablation of an anterior abdominal wall desmoid in familial adenomatous polyposis. Colorectal Disease, 15(3), e160-e163. DOI:10.1111/codi.12064. Publication link: 36eb0dd6-cd23-4fda-b3e5-494256979a8b | PubMed:23067141
  • Barrow, P. J., Ingham, S., O'Hara, C., Green, K., McIntyre, I., Lalloo, F., ... Evans, D. G. (2013). The spectrum of urological malignancy in Lynch syndrome. Familial Cancer, 12(1), 57-63. DOI:10.1007/s10689-012-9573-z. Publication link: 6b4dade8-f165-4699-adf0-3e5378e501f4 | PubMed:23054215
  • Basu, N. N., Littlechild, S., Evans, D. G., Ross, G. L., & Barr, L. (2013). Mastectomies of healthy, contralateral breasts in patients with breast cancer. British Journal of Hospital Medicine, 74(9), 486-487. . Publication link: 6ca1391d-72a0-4414-827c-3bbb66544bbb | PubMed:24022547
  • Ben-Shachar, S., Constantini, S., Hallevi, H., Sach, E. K., Upadhyaya, M., Evans, G. D., & Huson, S. M. (2013). Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: A novel genotype-phenotype correlation. European Journal of Human Genetics, 21(5), 535-539. DOI:10.1038/ejhg.2012.221. Publication link: 7dac0734-abe7-44bf-9d9a-14888f7d6c4e | PubMed:23047742
  • Bojesen, S. E., Pooley, K. A., Johnatty, S. E., Beesley, J., Michailidou, K., Tyrer, J. P., ... Pylkas, K. (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics, 45(4), 371-384. DOI:10.1038/ng.2566. Publication link: acb9b6f3-76e2-400d-a7b7-ecef43c0d63d | PubMed:23535731
  • Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., ... Eeles, R. (2013). Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Journal of Clinical Oncology, 31(14), 1748-1757. DOI:10.1200/JCO.2012.43.1882. Publication link: b62eb636-073b-4a48-a95d-1f2ffbf97c86 | PubMed:23569316
  • Den Heijer, M., Van Asperen, C. J., Harris, H., Nippert, I., Schmidtke, J., Bouhnik, A. D., ... Tibben, A. (2013). International variation in physicians' attitudes towards prophylactic mastectomy - Comparison between France, Germany, the Netherlands and the United Kingdom. European Journal of Cancer, 49(13), 2798-2805. DOI:10.1016/j.ejca.2013.04.025. Publication link: def9b7e0-8a37-4aa0-bba8-50c04f8cc0b8 | PubMed:23692813
  • Dombi, E., Ardern-Holmes, S. L., Babovic-Vuksanovic, D., Barker, F. G., Connor, S., Evans, D. G., ... REiNS International Collaboration, . U. (2013). Recommendations for imaging tumor response in neurofibromatosis clinical trials.Neurology, 81(21), S33-40. DOI:10.1212/ Publication link: 8a529f9d-2f8d-41f8-9f93-51bb539b1d62 | PubMed:24249804
  • Duffy, S. W., Mackay, J., Thomas, S., Anderson, E., Chen, T. H. H., Ellis, I., ... Caunt, J. (2013). Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: A single-arm cohort study. Health Technology Assessment, 17(11), 1-98. DOI:10.3310/hta17110. Publication link: d5017965-3bcb-4d22-b13f-8fc964550a05 | PubMed:23489892
  • Evans, D. G. R., & Ingham, S. L. (2013). Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Application of Clinical Genetics, 6, 53-61. DOI:10.2147/TACG.S35605. Publication link: ac2d76d5-de36-4638-a873-c3f4a3f690b7 | PubMed:23935382
  • Evans, D. G. R., Ingham, S. L., Baildam, A., Ross, G. L., Lalloo, F., Buchan, I., & Howell, A. (2013). Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer. Breast Cancer Research and Treatment, 140(1), 135-142. DOI:10.1007/s10549-013-2583-1. Publication link: 050e6735-6825-4ef8-93bf-8695f4069a67 | PubMed:23784379
  • Evans, D. G. R., Ingham, S. L., Buchan, I., Woodward, E. R., Byers, H., Howell, A., ... Lalloo, F. (2013). Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 22(12), 2269-2276. DOI:10.1158/1055-9965.EPI-13-0316-T. Publication link: 19a7eba8-a00c-4105-86f9-29a9fbab02b9 | PubMed:24285840
  • Evans, D. G. R., O'Hara, C., Wilding, A., Ingham, S. L., Howard, E., Dawson, J., ... Huson, S. M. (2013). Erratum: Mortality in neurofibromatosis 1: In North West England: An assessment of actuarial survival in a region of the UK since 1989 (European Journal of Human (2013) 21 (1031) DOI: 10.1038/ejhg.2013.121). European Journal of Human Genetics, 21(9), 1031. DOI:10.1038/ejhg.2013.121. Publication link: cc3f4e8f-30c6-472d-bcb0-fb9ba64b196d | PubMed:23949340
  • Evans, D. G. R., Wallace, A., & Newman, W. (2013). Can manipulation of splicing offer gene therapy possibilities to those with tumour-prone disorders?. European Journal of Human Genetics, 21(7), 701-702. DOI:10.1038/ejhg.2012.264. Publication link: d6db34cf-d71a-44ee-bd3c-dc20e45d28cd | PubMed:23188050
  • Evans, D. G., Graham, J., O'Connell, S., Arnold, S., & Fitzsimmons, D. (2013). Familial breast cancer: Summary of updated NICE guidance. BMJ, 346(7914), [f3829]. DOI:10.1136/bmj.f3829. Publication link: eb7ca9ba-e3df-40f3-a0ed-9278153794d5 | PubMed:23801680
  • Evans, G., Barrow, E., Hill, J., & Gareth Evans, D. (2013). Cancer risk in Lynch Syndrome. Familial Cancer, 12(2), 229-240. DOI:10.1007/s10689-013-9615-1. Publication link: fb24e9e6-01a3-40b6-8bea-0929a6405d19 | PubMed:23604856
  • Evans, G., Barrow, P., Khan, M., Lalloo, F., Evans, D. G., & Hill, J. (2013). Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. British Journal of Surgery, 100(13), 1719-1731. DOI:10.1002/bjs.9316. Publication link: 6bfc1c1c-bfa1-4383-a41e-cf4cfcd87453 | PubMed:24227356
  • Evans, G., Couch, F. J., Wang, X., McGuffog, L., Lee, A., Olswold, C., ... Dite, G. (2013). Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk. PLoS Genetics, 9(3), [e1003212]. DOI:10.1371/journal.pgen.1003212. Publication link: 0a0b96f0-c028-4e7f-be21-5ff5a1ad5eb5 | PubMed:23544013
  • Evans, G., Evans, D. G. R., Howell, A., Ingham, S. L., & Buchan, I. (2013). Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives. Breast Cancer Research, 15(1), 401. [401]. DOI:10.1186/bcr3382. Publication link: 66f3095b-ed10-4d68-b1bc-31fc5ced7bef | PubMed:23448362
  • Evans, G., Gaudet, M. M., Kuchenbaecker, K. B., Vijai, J., Klein, R. J., Kirchhoff, T., ... Snyder, C. L. (2013). Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk. PLoS Genetics, 9(3), [e1003173]. DOI:10.1371/journal.pgen.1003173. Publication link: 1c7d0f46-0ac6-4869-9f55-250e161c8b86 | PubMed:23544012
  • Evans, G., Howell, A., & Evans, D. G. (2013). Breast cancer prevention: SERMs come of age. The Lancet, 381(9880), 1795-1797. DOI:10.1016/S0140-6736(13)60443-2. Publication link: 2d1d60b8-ee1b-4c21-be10-32b54b9fb901 | PubMed:23639489
  • Evans, G., Ingham, S., Warwick, J., Byers, H., Lalloo, F., Newman, W., & Evans, D. (2013). Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK. Clinical Genetics, 84(1), 37-42. DOI:10.1111/cge.12035. Publication link: 3b4272c9-78a6-4bf2-a7a7-b9fcfaa395d0 | PubMed:23050611
  • Evans, G., Lucá, R., Averna, M., Zalfa, F., Vecchi, M., Bianchi, F., ... Bagni, C. (2013). The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO molecular medicine, 5(10), 1523-1536. DOI:10.1002/emmm.201302847. Publication link: 46b7ac55-de46-4103-b9ea-839e55602a0b | PubMed:24092663
  • Evans, G., Ruark, E., Snape, K., Humburg, P., Loveday, C., Bajrami, I., ... Newman, W. (2013). Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature, 493(7432), 406-410. DOI:10.1038/nature11725. Publication link: eb2ba62f-d225-4363-91d9-5d4d8670c187 | PubMed:23242139
  • Evans, G., Valentini, A., Lubinski, J., Byrski, T., Ghadirian, P., Moller, P., ... Narod, S. A. (2013). The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Research and Treatment, 142(1), 177-185. DOI:10.1007/s10549-013-2729-1. Publication link: 42076a43-2943-474e-8dfa-e474ddc5c2d0 | PubMed:24136669
  • Evans, G., Wright, E. M. M. B., Sach, E., Sharif, S., Quarrell, O., Carroll, T., ... Evans, D. G. R. (2013). Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis. Journal of Medical Genetics, 50(9), 606-613. DOI:10.1136/jmedgenet-2013-101648. Publication link: 61010943-f5ed-4e90-b721-5537486311ad | PubMed:23812910
  • Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, G., & Huson, S. M. (2013). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132(6), e1642-e1648. DOI:10.1542/peds.2013-1868. Publication link: f805aab4-a387-4048-b65b-d5acd0534cc0 | PubMed:24190681
  • Garg, S., Lehtonen, A., Huson, S. M., Emsley, R., Trump, D., Evans, D. G., & Green, J. (2013). Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study. Developmental Medicine and Child Neurology, 55(2), 139-145. DOI:10.1111/dmcn.12043. Publication link: 76730925-d0d0-4c78-bf29-cc5703ac87d2 | PubMed:23163236
  • Goorah, N., Singh, A., Stott, P., Levenson, R., Jordan, A., Joffe, J., ... Sharma, N. (2013). Correspondence - October 2013.British journal of hospital medicine (London, England : 2005), 74(10). . Publication link: fc945cca-3280-45a3-af4e-e95e5ce5b9e0 | PubMed:24105318
  • Harvie, M., Wright, C., Pegington, M., McMullan, D., Mitchell, E., Martin, B., ... Howell, A. (2013). The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women.British Journal of Nutrition, 110(8), 1534-1547. DOI:10.1017/S0007114513000792. Publication link: 75d3ba94-71be-4ea6-8685-f9f0c345df60 | PubMed:23591120
  • Ingham, S. L., Sperrin, M., Baildam, A., Ross, G. L., Clayton, R., Lalloo, F., ... Evans, D. G. R. (2013). Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.Breast Cancer Research and Treatment, 142(3), 611-618. DOI:10.1007/s10549-013-2765-x. Publication link: c4a87809-66b0-4105-a046-cc5a89e2e7ac | PubMed:24249359
  • Ingham, S. L., Warwick, J., Buchan, I., Sahin, S., O'Hara, C., Moran, A., ... Evans, D. G. (2013). Ovarian cancer among 8,005 women from a breast cancer family history clinic: no increased risk of invasive ovarian cancer in families testing negative for BRCA1 and BRCA2.Journal of medical genetics, 50(6), 368-372. DOI:10.1136/jmedgenet-2013-101607. Publication link: 049bd887-03fd-4202-8f4f-7a06067464a1 | PubMed:23539753
  • Jafri, M., Whitworth, J., Rattenberry, E., Vialard, L., Kilby, G., Kumar, A. V., ... Maher, E. R. (2013). Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Clinical Endocrinology, 78(6), 898-906. DOI:10.1111/cen.12074. Publication link: bbb35eec-0b61-47ab-bb19-a091fd5e8024 | PubMed:23072324
  • Killick, E., Morgan, R., Launchbury, F., Bancroft, E., Page, E., Castro, E., ... Pandha, H. (2013). Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.Scientific Reports, 3, 2059. DOI:10.1038/srep02059. Publication link: 0073249d-8fd8-4320-af37-7fcf54aaa825 | PubMed:23792811
  • Lloyd, S. K. W., & Evans, D. G. R. (2013). Neurofibromatosis type 2 (NF2): Diagnosis and management. Handbook of Clinical Neurology, 115, 957-967. DOI:10.1016/B978-0-444-52902-2.00054-0. Publication link: d1d73f48-bd91-41d9-9740-61d6c74e21bd | PubMed:23931824
  • Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., ... Easton, D. F. (2013). Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE. Journal of the National Cancer Institute, 105(11), 812-822. DOI:10.1093/jnci/djt095. Publication link: ffe59ebf-f66e-4ab3-9bfd-81458320962d | PubMed:23628597
  • Moffat, D. A., Lloyd, S. K. W., Macfarlane, R., Mannion, R., King, A., Rutherford, S., ... Ramsden, R. T. (2013). Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2. British Journal of Neurosurgery, 27(4), 446-453. DOI:10.3109/02688697.2013.771143. Publication link: 20e457c9-12b8-4f5f-802a-73b827cafe6f | PubMed:23472624
  • Newton, K. F., Green, K., Walsh, S., Lalloo, F., Hill, J., & Evans, D. G. R. (2013). Metachronous colorectal cancer risk in patients with a moderate family history. Colorectal Disease, 15(3), 309-316. DOI:10.1111/codi.12005. Publication link: 838e7847-cc07-4fef-a6cb-a335bd97ba9e | PubMed:22943508
  • Palles, C., Cazier, J. B., Howarth, K. M., Domingo, E., Jones, A. M., Broderick, P., ... Rimmer, A. (2013). Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nature Genetics, 45(2), 136-143. DOI:10.1038/ng.2503. Publication link: 228213f6-4cf7-4008-b555-ee2cafd11835 | PubMed:23263490
  • Pinheiro, M., Pinto, C., Peixoto, A., Veiga, I., Mesquita, B., Henrique, R., ... Teixeira, M. (2013). The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families. Clinical Genetics, 84(3), 244-250. DOI:10.1111/cge.12062. Publication link: 6e13e85a-ef46-4bd5-96b8-8abc4aed5fb3 | PubMed:23170986
  • Plotkin, S. R., Ardern-Holmes, S. L., Barker, F. G., Blakeley, J. O., Evans, D. G., Ferner, R. E., ... REiNS International Collaboration, . U. (2013). Hearing and facial function outcomes for neurofibromatosis 2 clinical trials.Neurology, 81(21), S25-32. DOI:10.1212/01.wnl.0000435746.02780.f6. Publication link: 16392cce-3776-4277-bd9e-6f61bdc599ee | PubMed:24249803
  • Rosenthal, A. N., Fraser, L., Manchanda, R., Badman, P., Philpott, S., Mozersky, J., ... Jacobs, I. J. (2013). Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. Journal of Clinical Oncology, 31(1), 49-57. DOI:10.1200/JCO.2011.39.7638. Publication link: 94a1d393-7771-4a11-a69d-d899cdd76cf3 | PubMed:23213100
  • Smith, M. J., O'Sullivan, J., Bhaskar, S. S., Hadfield, K. D., Poke, G., Caird, J., ... Evans, D. G. (2013). Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nature Genetics, 45(3), 295-298. DOI:10.1038/ng.2552. Publication link: 5988344b-15e4-45af-bb4f-1ddd54f7e2d2 | PubMed:23377182
  • Tilanus-Linthorst, M. M. A., Lingsma, H. F., Evans, D. G., Thompson, D., Kaas, R., Manders, P., ... Steyerberg, E. W. (2013). Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk. International Journal of Cancer, 133(1), 156-163. DOI:10.1002/ijc.28014. Publication link: 713665f1-26b2-49b8-8aa7-e6eeda113b59 | PubMed:23292943
  • Tysome, J. R., Axon, P. R., Donnelly, N. P., Evans, D. G., Ferner, R. E., O'Connor, A. F. F., ... Vanat, Z. H. (2013). English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2. Otology and Neurotology, 34(9), 1743-1747. DOI:10.1097/MAO.0b013e3182a1a8b4. Publication link: 0a7ac1f8-bd30-446b-83ef-d6c59bf6e646 | PubMed:24136318
  • Wang, D., Chen, X., Evans, D. G., & Yang, W. (2013). Well-dispersed Co3O4/Co2MnO4 nanocomposites as a synergistic bifunctional catalyst for oxygen reduction and oxygen evolution reactions. Nanoscale, 5(12), 5312-5315. DOI:10.1039/c3nr00444a. Publication link: 661ba1af-d6bb-4823-acf7-d461dd8152dd | PubMed:23681343


  • Aavikko, M., Li, S. P., Saarinen, S., Alhopuro, P., Kaasinen, E., Morgunova, E., ... Vahteristo, P. (2012). Loss of SUFU function in familial multiple meningioma. American Journal of Human Genetics, 91(3), 520-526. DOI:10.1016/j.ajhg.2012.07.015. Publication link: c0375cb1-079f-491a-95b8-2cb56a91bcb3 | PubMed:22958902
  • Blakeley, J. O., Evans, D. G., Adler, J., Brackmann, D., Chen, R., Ferner, R. E., ... Giovannini, M. (2012). Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. American Journal of Medical Genetics, Part A, 158(1), 24-41. DOI:10.1002/ajmg.a.34359. Publication link: 0ffb8f1c-1a82-4ddc-9dc9-ef6b2bfa2852 | PubMed:22140088
  • Bolton, K. L., Chenevix-Trench, G., Goh, C., Sadetzki, S., Ramus, S. J., Karlan, B. Y., ... Pharoah, P. D. P. (2012). Association between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer. Journal of the American Medical Association, 307(4), 382-390. DOI:10.1001/jama.2012.20. Publication link: 90ca63ad-5740-4905-a448-fd85729390ad | PubMed:22274685
  • Camp, N. J., Parry, M., Knight, S., Abo, R., Elliott, G., Rigas, S. H., ... Cox, A. (2012). Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiology Biomarkers and Prevention, 21(1), 176-181. DOI:10.1158/1055-9965.EPI-11-0845. Publication link: 70303b3b-4205-4773-a013-65d131091cdf | PubMed:22056502
  • Couch, F. J., Gaudet, M. M., Antoniou, A. C., Ramus, S. J., Kuchenbaecker, K. B., Soucy, P., ... Simard, J. (2012). Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers and Prevention, 21(4), 645-657. DOI:10.1158/1055-9965.EPI-11-0888. Publication link: 894d452d-a2a4-4bef-8b82-8e402e04feb9 | PubMed:22351618
  • Ding, Y. C., McGuffog, L., Healey, S., Friedman, E., Laitman, Y., Shimon, S. P., ... Neuhausen, S. L. (2012). A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology Biomarkers and Prevention, 21(8), 1362-1370. DOI:10.1158/1055-9965.EPI-12-0229. Publication link: b86c7e52-58e7-4522-9904-8a4477cbf39a | PubMed:22729394
  • Evans, D. G. L. F., Graham, J., O'Connell, S., Arnold, S., & Fitzsimmons, D. (2012). Familial Breast Cancer. Clin Genet. . Publication link: f69aae84-6ba7-4570-92f4-47ee62e6d2e3
  • Evans, D. G. R., Huson, S. M., & Birch, J. M. (2012). Malignant peripheral nerve sheath tumours in inherited disease.Clinical sarcoma research, 2(1). DOI:10.1186/2045-3329-2-17. Publication link: b0c9c70b-829c-4249-a32b-219726ca8512 | PubMed:23036231
  • Evans, D. G., Raymond, F. L., Barwell, J. G., & Halliday, D. (2012). Genetic testing and screening of individuals at risk of NF2. Clinical Genetics, 82(5), 416-424. DOI:10.1111/j.1399-0004.2011.01816.x. Publication link: be2e859a-7080-420b-9fc0-196e8b2b327a | PubMed:22098617
  • Evans, D. G., Warwick, J., Beetles, U., Warren, R., Hufton, A., Sergeant, J. C., ... Wilson, M. (2012). Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prevention Research, 5(7), 943-951. DOI:10.1158/1940-6207.CAPR-11-0458. Publication link: cd27de9d-64e9-432e-a808-1317411ba01b | PubMed:22581816
  • Evans, G., Antoniou, A. C., Kuchenbaecker, K. B., Soucy, P., Beesley, J., Chen, X., ... Rebbeck, T. (2012). Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research, 14(1), [R33]. DOI:10.1186/bcr3121. Publication link: f49751e6-947b-4918-aea0-6c1b7a17474d | PubMed:22348646
  • Evans, G., Barnes, D. R., Lee, A., EMBRACE Investigators, . U., kConFab Investigators, . U., Easton, D. F., & Antoniou, A. C. (2012). Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations.Genetic Epidemiology, 36(3), 274-291. DOI:10.1002/gepi.21620. Publication link: a5bf2aad-6636-45aa-bb45-ffdb2ad8286b | PubMed:22714938
  • Evans, G., Evans, D. G., & Howell, A. (2012). Are we ready for online tools in decision making for BRCA1/2 mutation carriers?. Journal of Clinical Oncology, 30(5), 471-473. DOI:10.1200/JCO.2011.40.1562. Publication link: 1021cefa-0b8c-42ea-9186-9b5341d44517 | PubMed:22231044
  • Evans, G., Kirchhoff, T., Offit, K., Gaudet, M. M., Pharoah, P. D. P., Easton, D. F., ... Gold, B. (2012). Breast cancer risk and 6q22.33: Combined results from breast cancer association consortium and consortium of investigators on modifiers of brca1/2. PLoS ONE, 7(6), [e35706]. DOI:10.1371/journal.pone.0035706. Publication link: 0e4e1a59-b1e1-4d34-8b7d-cde6d4af7a93 | PubMed:22768030
  • Evans, G., Ramus, S. J., Antoniou, A. C., Kuchenbaecker, K. B., Soucy, P., Beesley, J., ... Thomassen, M. (2012). Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human Mutation, 33(4), 690-702. DOI:10.1002/humu.22025. Publication link: c8c7deff-5aeb-4986-b452-2ac1b969f0f0 | PubMed:22253144
  • Evans, G., Spurdle, A. B., Healey, S., Devereau, A., Hogervorst, F. B. L., Monteiro, A. N. A., ... Goldgar, D. E. (2012). ENIGMA-evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Human Mutation, 33(1), 2-7. DOI:10.1002/humu.21628. Publication link: 018e052b-e45b-43f5-b056-c843c8768cd4 | PubMed:21990146
  • Evans, G., Wilding, A., Ingham, S. L., Lalloo, F., Clancy, T., Huson, S. M., ... Evans, D. G. (2012). Life expectancy in hereditary cancer predisposing diseases: An observational study. Journal of Medical Genetics, 49(4), 264-269. DOI:10.1136/jmedgenet-2011-100562. Publication link: ccf40bcd-0572-49f7-82e1-8c22d0e5b46f | PubMed:22362873
  • Ferraldeschi, R., Arnedos, M., Hadfield, K. D., A'Hern, R., Drury, S., Wardley, A., ... Dowsett, M. (2012). Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients. Breast Cancer Research and Treatment, 133(3), 1191-1198. DOI:10.1007/s10549-012-2010-z. Publication link: e458dbd6-191c-485e-b7de-b44db68fcd3a | PubMed:22418701
  • Finch, A., Evans, G., & Narod, S. A. (2012). BRCA carriers, prophylactic salpingo-oophorectomy and menopause: Clinical management considerations and recommendations. Women's Health, 8(5), 543-555. DOI:10.2217/whe.12.41. Publication link: 378c4127-3893-46d0-9577-4c48430f515f | PubMed:22934728
  • Finkelman, B. S., Rubinstein, W. S., Friedman, S., Friebel, T. M., Dubitsky, S., Schonberger, N. S., ... Rebbeck, T. R. (2012). Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. Journal of Clinical Oncology, 30(12), 1321-1328. DOI:10.1200/JCO.2011.37.8133. Publication link: 0105217e-6362-4a2b-907d-6fefcf7ac589 | PubMed:22430266
  • Hagel, C., Stemmer-Rachamimov, A. O., Bornemann, A., Schuhmann, M., Nagel, C., Huson, S., ... Mautner, V. F. (2012). Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas. Neuropathology, 32(6), 611-616. DOI:10.1111/j.1440-1789.2012.01306.x. Publication link: eae3f4e1-5de9-4477-a4d3-be4b17ae8794 | PubMed:22394059
  • Heijnsdijk, E. A. M., Warner, E., Gilbert, F. J., Tilanus-Linthorst, M. M. A., Evans, G., Causer, P. A., ... De Koning, H. J. (2012). Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI Screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiology Biomarkers and Prevention, 21(9), 1458-1468. DOI:10.1158/1055-9965.EPI-11-1196. Publication link: 2682b81f-7cde-4c65-ad25-cf32bf664a4f | PubMed:22744338
  • Howell, A., Astley, S., Beetles, U., Warren, R., Hufton, A., Sergeant, J., ... Wilson, M. (2012). Prevention of breast cancer in the context of a national breast screening programme. Journal of Internal Medicine, 271(4), 321-330. DOI:10.1111/j.1365-2796.2012.02525.x. Publication link: 2a3b19aa-1ad7-4cf6-bcb9-59381a622166 | PubMed:22292490
  • Iqbal, J., Ginsburg, O. M., Wijeratne, T. D., Howell, A., Evans, G., Sestak, I., & Narod, S. A. (2012). Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review. Cancer Treatment Reviews, 38(4), 318-328. DOI:10.1016/j.ctrv.2011.06.009. Publication link: a248824b-cb9b-4296-90eb-bd36f82c3de3 | PubMed:21775065
  • Jakubowska, A., Rozkrut, D., Antoniou, A., Hamann, U., Scott, R. J., McGuffog, L., ... Lubinski, J. (2012). Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: Results from a multicenter study. British Journal of Cancer, 106(12), 2016-2024. DOI:10.1038/bjc.2012.160. Publication link: 9580b321-f487-4857-a71e-355b0e6d640d | PubMed:22669161
  • Lalloo, F., & Evans, D. G. (2012). Familial Breast Cancer. Clinical Genetics, 82(2), 105-114. DOI:10.1111/j.1399-0004.2012.01859.x. Publication link: d2f14eea-0101-43ce-9c87-a954f329a978 | PubMed:22356477
  • Maia, A. T., Antoniou, A. C., O'Reilly, M., Samarajiwa, S., Dunning, M., Kartsonaki, C., ... Ponder, B. A. J. (2012). Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Research, 14(2), [R63]. DOI:10.1186/bcr3169. Publication link: b13cfb95-bf05-4b1a-baf9-a39868e10fea | PubMed:22513257
  • Mathers, J. C., Movahedi, M., Macrae, F., Mecklin, J. P., Moeslein, G., Olschwang, S., ... Burn, J. (2012). Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet Oncology, 13(12), 1242-1249. DOI:10.1016/S1470-2045(12)70475-8. Publication link: 00c0bf70-9920-4dde-a76a-3ed817fc6393 | PubMed:23140761
  • Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., ... Antoniou, A. C. (2012). Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology Biomarkers and Prevention, 21(1), 134-147. DOI:10.1158/1055-9965.EPI-11-0775. Publication link: 80352ba8-ac14-4cc2-8956-bd0829660d38 | PubMed:22144499
  • Moran, A., O'Hara, C., Khan, S., Shack, L., Woodward, E., Maher, E. R., ... Evans, D. G. R. (2012). Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. Familial Cancer, 11(2), 235-242. DOI:10.1007/s10689-011-9506-2. Publication link: 294b7adc-d3f0-4408-87d5-8a99afa82170 | PubMed:22187320
  • Ormondroyd, E., Donnelly, L., Moynihan, C., Savona, C., Bancroft, E., Evans, D. G., ... Watson, M. (2012). Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: A qualitative analysis. European Journal of Human Genetics, 20(1), 4-10. DOI:10.1038/ejhg.2011.146. Publication link: 8aed2dd2-2c1b-418d-9658-7adef32f7fe5
  • Pijpe, A., Andrieu, N., Easton, D. F., Kesminiene, A., Cardis, E., Noguès, C., ... Van Leeuwen, F. E. (2012). Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: Retrospective cohort study (GENE-RAD-RISK). BMJ, 345(7878), [e5660]. DOI:10.1136/bmj.e5660. Publication link: 825a245b-9431-49a8-9e53-1e3edf04b3cc | PubMed:22956590
  • Robertson, L., Hanson, H., Seal, S., Warren-Perry, M., Hughes, D., Howell, I., ... Rahman, N. (2012). BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. British Journal of Cancer, 106(6), 1234-1238. DOI:10.1038/bjc.2012.31. Publication link: 3c91f001-d81a-4a1f-bec3-3cad964414ba | PubMed:22333603
  • Rodriguez, F. J., Stratakis, C. A., & Evans, D. G. (2012). Genetic predisposition to peripheral nerve neoplasia: Diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathologica, 123(3), 349-367. DOI:10.1007/s00401-011-0935-7. Publication link: 2315890c-7849-442b-9865-a091b0f00133 | PubMed:22210082
  • Sidon, L., Ingham, S., Clancy, T., Clayton, R., Clarke, A., Jones, E. A., ... Evans, D. G. R. (2012). Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: Evidence for lower uptake in women affected by breast cancer and older women. British Journal of Cancer, 106(4), 775-779. DOI:10.1038/bjc.2011.573. Publication link: 9d5281bc-4b17-4ead-9232-7aedcc870d1b | PubMed:22187038
  • Smith, M. J., Kulkarni, A., Rustad, C., Bowers, N. L., Wallace, A. J., Holder, S. E., ... Evans, D. G. (2012). Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis. American Journal of Medical Genetics, Part A, 158(1), 215-219. DOI:10.1002/ajmg.a.34376. Publication link: 963fadb4-a0e2-4588-a63a-469a08012717 | PubMed:22105938
  • Smith, M. J., Wallace, A. J., Bowers, N. L., Rustad, C. F., Woods, C. G., Leschziner, G. D., ... Evans, D. G. R. (2012). Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics, 13(2), 141-145. DOI:10.1007/s10048-012-0319-8. Publication link: 1ec5a8b8-3ab9-4524-a663-05adce4d010e | PubMed:22434358
  • Sullivan, W., Evans, D. G., Newman, W. G., Ramsden, S. C., Scheffer, H., & Payne, K. (2012). Developing national guidance on genetic testing for breast cancer predisposition: The role of economic evidence?. Genetic Testing and Molecular Biomarkers, 16(6), 580-591. DOI:10.1089/gtmb.2011.0236. Publication link: be06a189-8d03-4287-8651-5498ba711d1e | PubMed:22313048
  • Turnbull, C., Seal, S., Renwick, A., Warren-perry, M., Hughes, D., Elliott, A., ... Rahman, N. (2012). Gene-gene interactions in breast cancer susceptibility. Human Molecular Genetics, 21(4), 958-962. [ddr525]. DOI:10.1093/hmg/ddr525. Publication link: 0d156376-b692-4c6a-9de6-4ab806606317 | PubMed:22072393
  • Evans, D. G., Kwong, A., & Dixon, M. J. (Ed.) (2012). Prevention of breast cancer: the genetics of breast cancer and risk reducing mastectomy.In A companion to Specialist Surgical Practice in Breast Surgery:. Philadelphia: Elsevier. . Publication link: 9b9d8352-e366-4f3b-94aa-7e4d8976616d
  • Evans, D. G., Sestak, I., Cuzick, J., Kwong, A., & Dixon, M. J. (Ed.) (2012). Prevention of breast cancer. In ABC of Breast Diseases. Chicago: Wiley-Blackwell. . Publication link: 03e1bca7-8cac-4180-8f87-d3115f820fa2


  • Baser, M. E., Friedman, J. M., Joe, H., Shenton, A., Wallace, A. J., Ramsden, R. T., & Evans, D. G. R. (2011). Empirical development of improved diagnostic criteria for neurofibromatosis 2. Genetics in Medicine, 13(6), 576-581. DOI:10.1097/GIM.0b013e318211faa9. Publication link: df2e7ab3-30eb-4162-b7d3-118477326500
  • Bourdeaut, F., Lequin, D., Brugières, L., Reynaud, S., Dufour, C., Doz, F., ... Delattre, O. (2011). Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clinical Cancer Research, 17(1), 31-38. DOI:10.1158/1078-0432.CCR-10-1795. Publication link: 7a4d2af5-d930-4ae2-b890-636089e55947
  • Burn, J., Bishop, D. T., Chapman, P. D., Elliott, F., Bertario, L., Dunlop, M. G., ... Mathers, J. C. (2011). A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prevention Research, 4(5), 655-665. DOI:10.1158/1940-6207.CAPR-11-0106. Publication link: 999ff6e5-10dd-42a5-b930-91a96f1a8a61
  • Burn, J., Gerdes, A. M., MacRae, F., Mecklin, J. P., Moeslein, G., Olschwang, S., ... Bishop, D. T. (2011). Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. The Lancet, 378(9809), 2081-2087. DOI:10.1016/S0140-6736(11)61049-0. Publication link: 99e39bb2-7363-43af-ab2f-02bb9210b171 | PubMed:22036019
  • Camp, N. J., Parry, M., Knight, S., Abo, R., Elliott, G., Rigas, S. H., ... Cox, A. (2011). Fine-mapping CASP8 risk variants in breast cancer.Cancer Epidemiol Biomarkers Prev.. . Publication link: 8a28aff6-8c35-4dd2-94eb-4025cd2df7b7
  • Evans, D. G. R. (2011). Medical management of neurofibromatosis. Paediatrics and Child Health, 21(10), 459-465. DOI:10.1016/j.paed.2011.02.003. Publication link: 3527c85d-4af9-4c03-abe1-392d4e6302ca
  • Evans, D. G. R., O'Hara, C., Wilding, A., Ingham, S. L., Howard, E., Dawson, J., ... Huson, S. M. (2011). Mortality in neurofibromatosis 1: In North West England: An assessment of actuarial survival in a region of the UK since 1989. European Journal of Human Genetics, 19(11), 1187-1191. DOI:10.1038/ejhg.2011.113. Publication link: f1f97e6f-292b-4cdc-bccd-7b3dc43a9fcd
  • Evans, D. G., Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D. M., ... Antoniou, A. C. (2011). Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).Cancer Epid Biomarkers Prev. . Publication link: 5217fe70-2d07-4edc-8a52-0069de998228
  • Evans, D. G., Raymond, F., Barwell, J., & Halliday, D. (2011). Genetic testing and screening of individuals at risk of NF2.Clin Genet. . Publication link: b673fd2e-9d64-4835-82f6-5ae418693135
  • Evans, G. R., Lloyd, S. K., & Ramsden, R. T. (2011). Neurofibromatosis type 2.Unknown Journal, 70, 91-98. . Publication link: 8df24f4f-5620-4c07-96c6-1e20d1942427
  • Evans, G., Antoniou, A. C., Kartsonaki, C., Sinilnikova, O. M., Soucy, P., McGuffog, L., ... Smalley, S. (2011). Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics, 20(16), 3304-3321. [ddr226]. DOI:10.1093/hmg/ddr226. Publication link: 24510b64-8492-43b7-b1fa-91ba1365fa76
  • Evans, G., Blakeley, J. O., Evans, D. G., Adler, J., Brackmann, D., Chen, R., ... Giovannini, M. (2011). Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.Unknown Journal. . Publication link: 8fb31de2-27f3-4246-a348-4473d5de3140
  • Evans, G., Challberg, J., Ashcroft, L., Lalloo, F., Eckersley, B., Clayton, R., ... Evans, D. G. (2011). Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: Significant bone health issues in those not taking HRT. British Journal of Cancer, 105(1), 22-27. DOI:10.1038/bjc.2011.202. Publication link: 74bdec30-5c5e-435a-800d-67af6f23917a
  • Evans, G., Cox, D. G., Simard, J., Sinnett, D., Hamdi, Y., Soucy, P., ... Vénat-Bouvet, L. (2011). Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics, 20(23), 4732-4747. [ddr388]. DOI:10.1093/hmg/ddr388. Publication link: 0ecddcf1-5eb7-4b68-b1d5-c154ed0fe8dd
  • Evans, G., Evans, D. G., Howell, A., Ward, D., Lalloo, F., Jones, J. L., & Eccles, D. M. (2011). Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. Journal of Medical Genetics, 48(8), 520-522. DOI:10.1136/jmedgenet-2011-100006. Publication link: f81df193-d765-41b9-a79f-1868182ec320
  • Evans, G., Evans, G. R., Lloyd, S. K. W., & Ramsden, R. T. (2011). Neurofibromatosis type 2. Advances in Oto-Rhino-Laryngology, 70, 91-98. DOI:10.1159/000322482. Publication link: db6f68f1-47a5-46c8-b489-0bfbf76d59ab | PubMed:21358190
  • Evans, G., Gadzicki, D., Evans, D. G., Harris, H., Julian-Reynier, C., Nippert, I., ... Schlegelberger, B. (2011). Genetic testing for familial/hereditary breast cancer - Comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. Journal of Community Genetics, 2(2), 53-69. DOI:10.1007/s12687-011-0042-4. Publication link: 8b304b03-f8e5-4562-9675-5d9cb957b641
  • Evans, G., Huson, S. M., Acosta, M. T., Belzberg, A. J., Bernards, A., Chernoff, J., ... Giancotti, F. G. (2011). Back to the future: Proceedings from the 2010 NF Conference. American Journal of Medical Genetics, Part A, 155(2), 307-321. DOI:10.1002/ajmg.a.33804. Publication link: df3a02e2-1219-4d58-85a0-2dc6c8030e0f
  • Evans, G., Maxwell, C. A., Benítez, J., Gómez-Baldó, L., Osorio, A., Bonifaci, N., ... Pujana, M. A. (2011). Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS biology, 9(11), [e1001199]. DOI:10.1371/journal.pbio.1001199. Publication link: ba75a463-0908-460c-88b7-17057fa5c0a2 | PubMed:22110403
  • Harvie, M. N., Pegington, M., Mattson, M. P., Frystyk, J., Dillon, B., Evans, G., ... Howell, A. (2011). The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: A randomized trial in young overweight women. International Journal of Obesity, 35(5), 714-727. DOI:10.1038/ijo.2010.171. Publication link: 91f07808-08c5-422c-85ae-ffa2f2d7e11f | PubMed:20921964
  • Howell, A., & Evans, G. D. (2011). Hormone replacement therapy and breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, 188, 115-124. DOI:10.1007/978-3-642-10858-7_10. Publication link: 7e85e287-bfa4-43d2-a049-937f97f764ad | PubMed:21253794
  • Hutton, J., Walker, L. G., Gilbert, F. J., Evans, D. G., Eeles, R., Kwan-Lim, G. E., ... Leach, M. O. (2011). Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: The MARIBS Study. British Journal of Cancer, 104(4), 578-586. DOI:10.1038/bjc.2011.1. Publication link: 544b189f-d547-494b-a175-f81c7a40e5ee
  • Im, K. M., Kirchhoff, T., Wang, X., Green, T., Chow, C. Y., Vijai, J., ... Gold, B. (2011). Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human Genetics, 130(5), 685-699. DOI:10.1007/s00439-011-1003-z. Publication link: 145e0de4-1772-4137-8568-bcf6c0d1c7af
  • Ingham, S., Huson, S. M., Moran, A., Wylie, J., Leahy, M., & Evans, D. G. R. (2011). Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent years. European Journal of Cancer, 47(18), 2723-2728. DOI:10.1016/j.ejca.2011.05.031. Publication link: 035e8de8-561c-4475-ad73-2f812c670fa2
  • Iqbal, J., Ginsburg, O. M., Wijeratne, T. D., Howell, A., Evans, G., Sestak, I., & Narod, S. A. (2011). Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review.Cancer Treat Rev. . Publication link: 841fa004-e1dc-497a-9c3c-94f89c09ff29
  • Knappskog, S., Bjørnslett, M., Myklebust, L. M., Huijts, P. E. A., Vreeswijk, M. P., Edvardsen, H., ... Lønning, P. E. (2011). The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians. Cancer Cell, 19(2), 273-282. DOI:10.1016/j.ccr.2010.12.019. Publication link: 57c7bbca-f214-44e5-be00-f654ebdeca3a | PubMed:21316605
  • Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., ... Rahman, N. (2011). Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nature Genetics, 43(9), 879-882. DOI:10.1038/ng.893. Publication link: 53590f4e-f591-4f60-8efe-64bc7d303246 | PubMed:21822267
  • Martrat, G., Maxwell, C. A., Tominaga, E., Porta-de-la-Riva, M., Bonifaci, N., Gómez-Baldó, L., ... Pujana, M. A. (2011). Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research, 13(2), [R40]. DOI:10.1186/bcr2862. Publication link: 7b2979e7-33a0-4a48-80fe-d68604d04047
  • Maurice, A., Evans, D. G., Affen, J., Greenhalgh, R., Duffy, S. W., & Howell, A. (2011). Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit.Int J Cancer. . Publication link: 6b826069-a19f-4dd7-b51f-30acdca8b1e0
  • Moran, A., O'Hara, C., Khan, S., Shack, L., Woodward, E., Maher, E. R., ... Evans, D. G. (2011). Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.Fam Cancer. . Publication link: e36a4932-36cc-422b-864b-656079f2a487
  • Mulligan, A. M., Couch, F. J., Barrowdale, D., Domchek, S. M., Eccles, D., Nevanlinna, H., ... Antoniou, A. C. (2011). Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research, 13(6), [R110]. DOI:10.1186/bcr3052. Publication link: 4948d430-2161-4789-9dcb-d14084045e93
  • Osorio, A., Milne, R. L., Alonso, R., Pita, G., Peterlongo, P., Teulé, A., ... Benítez, J. (2011). Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. British Journal of Cancer, 104(8), 1356-1361. DOI:10.1038/bjc.2011.91. Publication link: b4b31f99-b321-4ecb-8301-d5797b3e67b7
  • Rebbeck, T. R., Mitra, N., Domchek, S. M., Wan, F., Friebel, T. M., Tran, T. V., ... Nathanson, K. L. (2011). Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Cancer Research, 71(17), 5792-5805. DOI:10.1158/0008-5472.CAN-11-0773. Publication link: c002afb7-1dcb-4d05-840b-6c2e04e62070
  • Sharif, S., Upadhyaya, M., Ferner, R., Majounie, E., Shenton, A., Baser, M., ... Evans, D. G. (2011). A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations.J Med Genet. . Publication link: e5a5b4cb-631a-450e-9bc2-5b35a850998f
  • Sidon, L., Ingham, S., Clancy, T., Clayton, R., Clarke, A., Jones, E. A., ... Evans, D. G. (2011). Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women.Br J Cancer.. . Publication link: 2466946c-e08a-4b10-8a36-a6459a9fa882
  • Smith, M. J., Higgs, J. E., Bowers, N. L., Halliday, D., Paterson, J., Gillespie, J., ... Evans, D. G. R. (2011). Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: Clear positional effect of mutations, but absence of female severity effect on age at onset. Journal of Medical Genetics, 48(4), 261-265. DOI:10.1136/jmg.2010.085241. Publication link: a972a9e7-c07d-4d21-9309-a6abfbc603b0
  • Smith, M. J., Kulkarni, A., Rustad, C., Bowers, N. L., Wallace, A. J., Holder, S. E., ... Evans, D. G. (2011). Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.Am J Med Genet A. . Publication link: 4205d0cd-8ec9-4de6-9d0b-a5faecfe9eac
  • Speake, D., O'Sullivan, J., Evans, D. G., Lalloo, F., Hill, J., & McMahon, R. F. (2011). Hyperplastic polyps are innocuous lesions in hereditary nonpolyposis colorectal cancers. International Journal of Surgical Oncology, 2011, [653163]. DOI:10.1155/2011/653163. Publication link: d41d408b-10a3-470a-bfbd-fbe62235058a | PubMed:22312515
  • Thompson, A. M., Johnson, A., Quinlan, P., Hillman, G., Fontecha, M., Bray, S. E., ... Newman, W. G. (2011). Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Research and Treatment, 125(1), 279-287. DOI:10.1007/s10549-010-1139-x. Publication link: 8795234d-6ed3-4c11-add7-7c7516d321c0 | PubMed:20809362
  • Turnbull, C., Seal, S., Renwick, A., Warren-Perry, M., Hughes, D., Elliott, A., ... Rahman, N. (2011). Gene-gene interactions in breast cancer susceptibility.Hum Molec Genet. . Publication link: 2295f749-c9f8-4633-beca-8da307553f1c
  • Evans, D. G. R., Lloyd, S. K. W., & Ramsden, R. T. R. (2011). Neurofibromatosis type 2.In Medical Genetics in the Clinical Practice of ORL. (pp. 9198). Karger,. . Publication link: 604d57e7-1e2a-4ea1-a3ed-9201842d0393


  • Antoniou, A. C., Wang, X., Fredericksen, Z. S., McGuffog, L., Tarrell, R., Sinilnikova, O. M., ... Couch, F. J. (2010). A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics, 42(10), 885-892. DOI:10.1038/ng.669. Publication link: 2a9802df-990b-4d23-9e7b-e1f613ca95b9
  • Bergqvist, J., Latif, A., Roberts, S. A., Hadfield, K. D., Lalloo, F., Howell, A., ... Newman, W. G. (2010). RASSF1A polymorphism in familial breast cancer. Familial Cancer, 9(3), 263-265. DOI:10.1007/s10689-010-9335-8. Publication link: 035b7643-8312-4e1a-bc42-9c0dcf1791ff | PubMed:20361264
  • Cairns, S. R., Scholefield, J. H., Steele, R. J., Dunlop, M. G., Thomas, H. J. W., Evans, G. D., ... Woodhouse, C. R. J. (2010). Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut, 59(5), 666-689. DOI:10.1136/gut.2009.179804. Publication link: b63ce786-1e40-427d-b032-3feb9176dd0d
  • Craddock, N., Hurles, M. E., Cardin, N., Pearson, R. D., Plagnol, V., Robson, S., ... Donnelly, P. (2010). Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature, 464(7289), 713-720. DOI:10.1038/nature08979. Publication link: b94fb048-f1ee-42d2-b9df-f0a9854d562f | PubMed:20360734
  • Domchek, S. M., Friebel, T. M., Garber, J. E., Isaacs, C., Matloff, E., Eeles, R., ... Rebbeck, T. R. (2010). Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers. Breast Cancer Research and Treatment, 124(1), 195-203. DOI:10.1007/s10549-010-0799-x. Publication link: 8cba778a-83e9-4e78-8b4e-80cab59eb893
  • Edwards, S. M., Evans, D. G. R., Hope, Q., Norman, A. R., Barbachano, Y., Bullock, S., ... Eeles, R. A. (2010). Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis. British Journal of Cancer, 103(6), 918-924. DOI:10.1038/sj.bjc.6605822. Publication link: 80f7d1f4-4a99-4a86-ba80-540c1c058bd0
  • Engel, C., Versmold, B., Wappenschmidt, B., Simard, J., Easton, D. F., Peock, S., ... Schmutzler, R. K. (2010). Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers and Prevention, 19(11), 2859-2868. DOI:10.1158/1055-9965.EPI-10-0517. Publication link: bb305a75-12b2-47b4-a6dd-fffedc267018
  • Evans, D. G. R., Susnerwala, I., Dawson, J., Woodward, E., Maher, E. R., & Lalloo, F. (2010). Risk of breast cancer in male BRCA2 carriers. Journal of Medical Genetics, 47(10), 710-711. DOI:10.1136/jmg.2009.075176. Publication link: 9b4c4a77-9f9f-4931-9f5c-bc7ae55b2802
  • Evans, D. G., Harvie, M., Bundred, N., & Howell, A. (2010). Uptake of breast cancer prevention and screening trials. Journal of Medical Genetics, 47(12), 853-855. DOI:10.1136/jmg.2010.082768. Publication link: c44b058d-ef7e-4927-b3f4-40d2f83ecfdd | PubMed:20972247
  • Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M., & Lalloo, F. (2010). Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. American Journal of Medical Genetics, Part A, 152(2), 327-332. DOI:10.1002/ajmg.a.33139. Publication link: f8b2b3d3-76a7-4df8-b9df-5412ab8327d9
  • Evans, D. G., Lunt, P., Clancy, T., & Eeles, R. (2010). Childhood predictive genetic testing for Li-Fraumeni syndrome. Familial Cancer, 9(1), 65-69. DOI:10.1007/s10689-009-9245-9. Publication link: 4947ed5e-64a9-49aa-86fc-c9b9c74883a3
  • Evans, G. (2010). Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D et al. Clinical Cancer Research, 15(16), 5032-5039. . Publication link: c93bb83e-6060-468b-a690-44e5097d42d0
  • Evans, G. R., & Lalloo, F. (2010). Development of a scoring system to screen for BRCA1/2 mutations.Methods in Molecular Biology, 653, 237-247. DOI:10.1007/978-1-60761-759-4_14. Publication link: 7b8d1b03-bc59-4c9c-a709-f9343bef379e
  • Evans, G., & Duffy, S. W. (2010). Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: Tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncology, 11(12), 1127-1134. DOI:10.1016/S1470-2045(10)70263-1. Publication link: cf4af7df-2dd6-4887-9d22-f21f58c26220
  • Evans, G., & Men, T. P. C. S. I. (2010). Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.BJU INT. . Publication link: 1d4fb2bd-7f13-4e49-9776-8b2d5b4fde96
  • Evans, G., Amir, E., Freedman, O. C., Seruga, B., & Evans, D. G. (2010). Assessing women at high risk of breast cancer: A review of risk assessment models. Journal of the National Cancer Institute, 102(10), 680-691. DOI:10.1093/jnci/djq088. Publication link: 56382d69-d0d3-487f-bec2-688eaa26d880
  • Evans, G., Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., ... Easton, D. F. (2010). Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction. Cancer Research, 70(23), 9742-9754. DOI:10.1158/0008-5472.CAN-10-1907. Publication link: 3ab6a50b-07ef-45c9-827d-9f38f82411c8
  • Evans, G., Domchek, S. M., Friebel, T. M., Singer, C. F., Gareth Evans, D., Lynch, H. T., ... Rebbeck, T. R. (2010). Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. Journal of the American Medical Association, 304(9), 967-975. DOI:10.1001/jama.2010.1237. Publication link: 4b3b6a35-869f-48e9-bc92-000212b8f584
  • Evans, G., Evans, D. G. R., Moran, A., Hartley, R., Dawson, J., Bulman, B., ... Lalloo, F. (2010). Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status. British Journal of Cancer, 102(7), 1091-1098. DOI:10.1038/sj.bjc.6605606. Publication link: f147820d-95de-4ee0-a219-f44008838dc6
  • Evans, G., Evans, D. G., Ahmed, M., Bayliss, S., Howard, E., Lalloo, F., & Wallace, A. (2010). BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries. Journal of Medical Genetics, 47(8), 561-566. DOI:10.1136/jmg.2009.075770. Publication link: 8cbf810d-b206-4403-a130-e4f25fd3ca52
  • Evans, G., Latif, A., McBurney, H. J., Roberts, S. A., Lalloo, F., Howell, A., ... Newman, W. G. (2010). Breast cancer susceptibility variants alter risk in familial ovarian cancer. Familial Cancer, 9(4), 503-506. DOI:10.1007/s10689-010-9349-2. Publication link: b0084af6-3607-4ada-b03a-e5c4f9a26420
  • Evans, G., Turnbull, C., Hines, S., Renwick, A., Hughes, D., Pernet, D., ... Rahman, N. (2010). Mutation and association analysis of GEN1 in breast cancer susceptibility. Breast Cancer Research and Treatment, 124(1), 283-288. DOI:10.1007/s10549-010-0949-1. Publication link: dd331bc2-ba24-4fdd-aca8-c41b4c48c572
  • Hadfield, K. D., Smith, M. J., Trump, D., Newman, W. G., & Evans, D. G. (2010). SMARCB1 mutations are not a common cause of multiple meningiomas. Journal of Medical Genetics, 47(8), 567-568. DOI:10.1136/jmg.2009.075721. Publication link: a4e8560f-120b-45d8-bf36-7a101898229b | PubMed:20472658
  • Hadfield, K. D., Smith, M. J., Urquhart, J. E., Wallace, A. J., Bowers, N. L., King, A. T., ... Evans, D. G. (2010). Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene, 29(47), 6216-6221. DOI:10.1038/onc.2010.363. Publication link: bb04f303-7699-4bf7-83b7-bd9ba51f4f68 | PubMed:20729918
  • Houlston, R. S., Cheadle, J., Dobbins, S. E., Tenesa, A., Jones, A. M., Howarth, K., ... Tomlinson, I. P. M. (2010). Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nature Genetics, 42(11), 973-977. DOI:10.1038/ng.670. Publication link: 8af8d062-6a59-4625-8099-9030623af571
  • Latif, A., Hadfield, K. D., Roberts, S. A., Shenton, A., Lalloo, F., Black, G. C. M., ... Newman, W. G. (2010). Breast cancer susceptibility variants alter risks in familial disease. Journal of Medical Genetics, 47(2), 126-131. DOI:10.1136/jmg.2009.067256. Publication link: f7093ba0-7411-41ca-a5c2-f83bca373c26 | PubMed:19617217
  • Mallinson, E. K. L., Newton, K. F., Bowen, J., Lalloo, F., Clancy, T., Hill, J., & Evans, D. G. R. (2010). The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis. Gut, 59(10), 1378-1382. DOI:10.1136/gut.2010.212449. Publication link: 4815f398-e01f-4183-9048-2e66f5bc1f9e
  • Mcmahon, R., Barrow, E., Jagger, E., Brierley, J., Wallace, A., Evans, G., ... McMahon, R. (2010). Semiquantitative assessment of immunohistochemistry for mismatch repair proteins in Lynch syndrome. Histopathology, 56(3), 331-344. DOI:10.1111/j.1365-2559.2010.03485.x. Publication link: 8b20fc49-79fb-4553-8d69-276c3b6a52f0
  • Neary, W. J., Hillier, V. F., Flute, T., Stephens, D., Ramsden, R. T., & Evans, D. G. R. (2010). Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2. The Journal of laryngology and otology, 124(7), 720-728. DOI:10.1017/S0022215110000460. Publication link: a57307fa-74b4-44bd-9aad-8f0eebca3d84
  • Neary, W. J., Hillier, V. F., Flute, T., Stephens, S. D. G., Ramsden, R. T., & Evans, D. G. R. (2010). The relationship between patients' perception of the effects of neurofibromatosis type 2 and the domains of the Short Form-36. Clinical Otolaryngology, 35(4), 291-299. DOI:10.1111/j.1749-4486.2010.02176.x. Publication link: ea03f031-aaa9-4a3e-b906-9fdcc88fd9eb
  • Ramus, S. J., Kartsonaki, C., Gayther, S. A., Pharoah, P. D., Sinilnikova, O. M., Beesley, J., ... Soucy, P. (2010). Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers.J Natl Cancer Inst. . Publication link: 2f5fe4e5-8c46-48e2-bbf2-cd2124b25ec7
  • Selvanathan, S. K., Shenton, A., Ferner, R., Wallace, A. J., Huson, S. M., Ramsden, R. T., & Evans, D. G. (2010). Further genotype - phenotype correlations in neurofibromatosis 2. Clinical Genetics, 77(2), 163-170. DOI:10.1111/j.1399-0004.2009.01315.x. Publication link: 499d3807-903b-4940-a49c-9aad4d9ebf28
  • Smith, M. J., Hadfield, K. D., Ramsden, R. T., Rutherford, S. A., King, A. T., Newman, W. G., & Evans, D. G. (2010). Isolated unilateral vestibular schwannomas do not harbor HRAS mutations. American Journal of Medical Genetics, Part A, 152(6), 1586-1587. DOI:10.1002/ajmg.a.33409. Publication link: c22305ce-7556-4387-a991-90922a9f68d9 | PubMed:20503341
  • Suryanarayanan, R., Ramsden, R. T., Saeed, S. R., Aggarwal, R., King, A. T., Rutherford, S. A., ... Gillespie, J. E. (2010). Vestibular schwannoma: Role of conservative management. The Journal of laryngology and otology, 124(3), 251-257. DOI:10.1017/S0022215109992362. Publication link: 672ccc6a-4cbd-4e4e-9807-e5e9a5b728bd
  • Turnbull, C., Ahmed, S., Morrison, J., Pernet, D., Renwick, A., Maranian, M., ... Easton, D. F. (2010). Genome-wide association study identifies five new breast cancer susceptibility loci. Nature Genetics, 42(6), 504-507. DOI:10.1038/ng.586. Publication link: 045c2f8d-ac7c-4927-b6bf-e7bf8f973a48
  • Walker, L. C., Fredericksen, Z. S., Wang, X., Tarrell, R., Pankratz, V. S., Lindor, N. M., ... Couch, F. J. (2010). Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research, 12(6), [R102]. DOI:10.1186/bcr2785. Publication link: e5e9579f-b20a-463d-8564-b6073e5df226
  • Whitaker, H. C., Kote-Jarai, Z., Ross-Adams, H., Warren, A. Y., Burge, J., George, A., ... Neal, D. E. (2010). The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS ONE, 5(10), [e13363]. DOI:10.1371/journal.pone.0013363. Publication link: 3d5c598c-7db0-45bc-9164-b98a93d8cc6e
  • Wilson, J. R. F., Bateman, A. C., Hanson, H., An, Q., Evans, G., Rahman, N., ... Eccles, D. M. (2010). A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations. Journal of Medical Genetics, 47(11), 771-774. DOI:10.1136/jmg.2010.078113. Publication link: a5cd316c-8444-4ef6-bb60-236475f6de07


  • Barrow, E., Robinson, L., Alduaij, W., Shenton, A., Clancy, T., Lalloo, F., ... Evans, D. G. (2009). Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations. Clinical Genetics, 75(2), 141-149. DOI:10.1111/j.1399-0004.2008.01125.x. Publication link: 1a0af6f8-5a71-4ba3-b3eb-9ae9c9b3fdc5
  • Evans, D. G. R. (2009). Neurofibromatosis type 2 (NF2): A clinical and molecular review. Orphanet Journal of Rare Diseases, 4(1), [16]. DOI:10.1186/1750-1172-4-16. Publication link: 19c96b7c-783a-4d44-b9dc-2800be856ac4
  • Evans, D. G., Gaarenstroom, K. N., Stirling, D., Shenton, A., Maehle, L., Dørum, A., ... Moller, P. (2009). Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers. Journal of Medical Genetics, 46(9), 593-597. DOI:10.1136/jmg.2008.058248. Publication link: aea60b3e-4208-4961-9600-00a45a53a595
  • Evans, G. (2009). Ahmed M, Lalloo F, Evans DG. Update on genetic predisposition to breast cancer. Expert Rev Anticancer Ther, 9(8):(8), 1103-1113. . Publication link: dab9a42e-72d3-4a01-bb0f-ecccd1e1b46d
  • Evans, D. G. R., Assessment, B. A. D. R., & Management, . U. (2009). Risk assessment and Management. In host publication.. Publication link: 0110c22e-b4d9-4a93-9470-7a83112667d3
  • Evans, G. (2009). Prevention of breast cancer: the genetics of breast cancer and risk reducing mastectomy.In Breast Surgery: A companion to Specialist Surgical Practice. Elsevier,. (pp. 125). Publication link: b40f0402-964e-4e6c-a737-752b91286cd7



  • Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Duncanson, A., Kwiatkowski, D. P., ... Hider, S. (2007). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics, 39(11), 1329-1337. DOI:10.1038/ng.2007.17. Publication link: 68149a9e-dc3e-440b-b7ad-605a11625e24
  • Evans, G., Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., ... Kirby, A. (2007). Guidelines for the diagnosis and management of individuals with neurofibromatosis. Journal of Medical Genetics, 44(2), 81-88. DOI:10.1136/jmg.2006.045906. Publication link: d9600018-f20f-4ad9-806e-2d467ec5cc2d


  • Bramley, M., Clarke, R., Howell, A., Evans, D. G. R., Armer, T., Baildam, A. D., & Anderson, E. (2006). Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations. British Journal of Cancer, 94(7), 1021-1028. DOI:10.1038/sj.bjc.6603042. Publication link: a32de9fd-edcf-4a25-9c54-71c06c139f70
  • Evans, D. G. R., Birch, J. M., Ramsden, R. T., Sharif, S., & Baser, M. E. (2006). Malignant transformation and new primary tumours after therapeutic radiation for benign disease: Substantial risks in certain tumour prone syndromes. Journal of Medical Genetics, 43(4), 289-294. DOI:10.1080/13621020600772081. Publication link: 9e777d6f-d41c-4886-a4be-c86232cf449a
  • Lalloo, F., Varley, J., Moran, A., Ellis, D., O'Dair, L., Pharoah, P., ... Evans, D. G. R. (2006). BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. European Journal of Cancer, 42(8), 1143-1150. DOI:10.1016/j.ejca.2005.11.032. Publication link: 938c0306-ee6a-46ce-a198-feb2c6207e35



  • Brooks, L., Lennard, F., Shenton, A., Lalloo, F., Ambus, I., Ardern-Jones, A., ... Evans, D. G. (2004). BRCA1/2 predictive testing: A study of uptake in two centres. European Journal of Human Genetics, 12(8), 654-662. DOI:10.1038/sj.ejhg.5201206. Publication link: 8195a0e0-20f2-40d6-9628-8ddf78e4d2c9
  • Wallace, A. J., Watson, C. J., Howard, E., Evans, D. G. R., & Elles, R. G. (2004). Mutation scanning of the NF2 gene: An improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis. Genetic testing, 8(4), 368-380. DOI:10.1089/gte.2004.8.368. Publication link: 371d0fca-7711-4234-9520-08c9344a76c7



  • Baser, M. E., Friedman, J. M., Aeschliman, D., Joe, H., Wallace, A. J., Ramsden, R. T., ... Evans, R. (2002). Predictors of the risk of mortality in neurofibromatosis 2. American Journal of Human Genetics, 71(4), 715-723. DOI:10.1086/342716. Publication link: d36763d4-455a-494e-9216-6f068153a116
  • Bennett, K. E., Howell, A., Evans, D. G. R., & Birch, J. M. (2002). A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients. British Journal of Cancer, 86(5), 718-722. DOI:10.1038/sj.bjc.6600106. Publication link: 9ce00693-041f-49a5-952b-39e70eac9853
  • Evans, D. D. G. R., Moran, A., Baser, M., McGaughran, J., Sharif, S., & Howard, E. (2002). Malignant peripheral nerve sheath tumours in neurofibromatosis 1.J Med Genet, 39( 5), 311-4. . Publication link: 16a91511-c986-46cb-859b-c1e851894b76
  • Evans, D. D. G. R., Varley, J. M., Thorneycroft, M., McGown, G., Lalloo, F., & Birch, J. M. (2002). Low rate of TP53 germline mutations in breast/sarcoma families not fulfilling classical criteria for Li Fraumeni syndrome.Journal of Medical Genetics, 39, 941-944. DOI:10.1136/jmg.39.12.941. Publication link: e96cce37-09f1-46c2-801c-bdecf7955348
  • Hewitt, C., Wu, C. L., Evans, G., Howell, A., Elles, R. G., Jordan, R., ... Thakker, N. (2002). Germline mutation of ARF in a melanoma kindred. Human Molecular Genetics, 11(11), 1273-1279. DOI:10.1093/hmg/11.11.1273. Publication link: e08a5fdf-9eaf-45ed-af3e-fff712006c74 | PubMed:12019208
  • Kerr, B., Birch, J. M., Evans, D. D. G. R., Singhal, S., & Lashford, L. (2002). Clinical characteristics of symptomatic sporadic and NF1 related optic gliomata: implications for management. Archives of Diseases in Childhood, 87, 65-70. . Publication link: da0d6ac0-3b85-4779-8dd7-1b931d7b700d


  • Baria, K., Warren, C., Roberts, S. A., West, C. M. L., Evans, D. G. R., Varley, J. M., & Scott, D. (2001). Correspondence re: A. Rothfuss et al., Induced micronucleus frequencies in peripheral blood lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer res., 60: 390-394, 2000 [1]. Cancer Research, 61(15), 5948-5949. . Publication link: 61794cd8-9413-40af-8efc-44cbd045e857
  • Baria, K., Warren, C., Roberts, S. A., West, C. M. L., Evans, D. G. R., Varley, J. M., & Scott, D. (2001). Correspondence re: A. Rothfuss et al., Induced micronucleus frequencies in peripheral blood lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer res., 60: 390-394, 2000 [1]. Cancer Research, 61(15), 5948-5949. . Publication link: d2cdd95d-6b61-44b0-96a3-0733349600b8
  • Birch, J. M., Alston, R. D., McNally, R. J. Q., Evans, D. G. R., Kelsey, A. M., Harris, M., ... Varley, J. M. (2001). Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene, 20(34), 4621-4628. DOI:10.1038/sj.onc.1204621. Publication link: a4baa9f0-d6d5-46ff-9550-fa2454019259 | PubMed:11498785


  • Varley, J. M., Evans, D. D. G. R., Birch, J. M., Boyle, J. M., James, L. A., McGown, G., ... Kelsey, A. (2000). Genetic and cytogenetic studies in inherited cancer: Li Fraumeni syndrome. Chromosomes Today, 13, 245-255. . Publication link: a1b3567d-7622-46f1-95da-97c098673187
  • Woodford-Richens, K., Tomlinson, P. M. I., Bevan, S., Houlston, R. S., Churchman, M., Dowling, B., ... Bodmer, W. F. (2000). Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut, 46(5), 656-660. DOI:10.1136/gut.46.5.656. Publication link: ab0e49af-e553-4d62-bf3e-c5fb13a9112f | PubMed:10764709


  • Chang-Claude, J., Becher, H., Caligo, M., Eccles, D., Evans, G., Haites, N., ... Stoppa-Lyonnet, D. (1999). Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast Cancer.Disease markers, 15(1-3). . Publication link: 61365584-e8d7-4c41-9ac3-8762bc339085 | PubMed:10595253
  • Douglas, F. S., O'Dair, L. C., Robinson, M., Evans, D. G. R., & Lynch, S. A. (1999). The accuracy of diagnoses as reported in families with cancer: A retrospective study. Journal of Medical Genetics, 36(4), 309-312. . Publication link: bbd7ac19-58be-4a1e-8b31-ec84cc44faa0 | PubMed:10227399
  • Eccles, D. M., Simmonds, P., Goddard, J., Coultas, M., Lalloo, F., Evans, G., & Haites, N. (1999). Management of hereditary breast cancer. European Familial Breast Cancer Collaborative Group.Disease markers, 15(1-3). . Publication link: dc73b670-3300-4c46-bed5-b43efdfd6013 | PubMed:10595276
  • Evans, D. G. R., Anderson, E., Lalloo, F., Vasen, H., Beckmann, M., Eccles, D., ... Haites, N. (1999). Utilisation of prophylactic mastectomy in 10 European centres. Disease Markers, 15(1-3), 148-151. . Publication link: 3d633630-cdda-4bb6-8df4-e7bfc8b3692b | PubMed:10595270
  • Evans, D. G. R., Birch, J. M., & Ramsden, R. T. (1999). Paediatric presentation of type 2 neurofibromatosis. Archives of Disease in Childhood, 81(6), 496-499. . Publication link: 7bdbb82d-4c84-4716-a70f-caf207b006fd | PubMed:10569966
  • Evans, G., & Evans, D. G. (1999). Neurofibromatosis type 2: Genetic and clinical features. Ear, Nose and Throat Journal, 78(2), 97-100. . Publication link: faa47339-959a-4473-9e1d-4c7a562934b5 | PubMed:10089694
  • Froggatt, N. J., Green, J., Brassett, C., Evans, D. G. R., Bishop, D. T., Kolodner, R., & Maher, E. R. (1999). A common MSH2 mutation in English and North American HNPCC families: Origin, phenotypic expression, and sex specific differences in colorectal cancer. Journal of Medical Genetics, 36(2), 97-102. . Publication link: 8de7cb5c-5e75-43b2-8eda-f09d4abcab93 | PubMed:10051005
  • Hodgson, S., Milner, B., Brown, I., Bevilacqua, G., Chang-Claude, J., Eccles, D., ... Haites, N. (1999). Cancer genetics services in Europe. Disease Markers, 15(1-3), 3-13. . Publication link: 4d638032-8724-42ef-b004-4f9228605332 | PubMed:10595245
  • Moller, P., Evans, G., Haites, N., Vasen, H., Reis, M. M., Anderson, E., ... Steel, C. M. (1999). Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on inherited breast cancer. Disease Markers, 15(1-3), 207-211. . Publication link: 6845358f-fb03-4c74-8b4b-970ba3a3f760 | PubMed:10595280
  • Møller, P., Reis, M. M., Evans, G., Vasen, H., Haites, N., Anderson, E., ... Heimdal, K. (1999). Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.Disease markers, 15(1-3). . Publication link: dffe4c05-ba16-4f78-ba6a-be0c298cea2b | PubMed:10595275
  • Morrison, P. J., Steel, C. M., Vasen, H. F. A., Eccles, D., Evans, D. G. R., Moller, P., ... Nevin, N. C. (1999). Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe. Disease Markers, 15(1-3), 159-165. . Publication link: 8c4c3b47-61c3-4283-870f-fa6f73bc34ed | PubMed:10595272
  • Richards, F. M., McKee, S. A., Rajpar, M. H., Cole, T. R. P., Evans, D. G. R., Jankowski, J. A., ... Maher, E. R. (1999). Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Human Molecular Genetics, 8(4), 607-610. . Publication link: f4afeaf7-fbd3-485f-a9bb-0bf9788e5cec | PubMed:10072428
  • Roberts, S., Roberts, S. A., Spreadborough, A. R., Bulman, B., Barber, J. B. P., Evans, D. G. R., & Scott, D. (1999). Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer?. American Journal of Human Genetics, 65(3), 784-794. DOI:10.1086/302544. Publication link: 564893e1-4ae8-4e3a-9834-a866133b83df | PubMed:10441587
  • Steel, M., Smyth, E., Vasen, H., Eccles, D., Evans, G., Moller, P., ... Haites, N. (1999). Ethical, social and economic issues in familial breast cancer: A compilation of views from the E.C. Biomed II Demonstration Project. Disease markers, 15(1-3), 125-131. . Publication link: b94547d8-1438-40f3-857c-8efd0b807387 | PubMed:10595265
  • Stoppa-Lyonnet, D., Caligo, M., Eccles, D., Evans, D. G. R., Haites, N. E., Hodgson, N. S., ... Chang-Claude, J. (1999). Genetic testing for breast cancer predisposition in 1999: Which molecular strategy and which family criteria?. Disease markers, 15(1-3), 67-68. . Publication link: 2e08bb27-59dc-4b56-911f-e06b83ba546a | PubMed:10595254
  • Stratton, J. F., Thompson, D., Bobrow, L., Dalal, N., Gore, M., Bishop, D. T., ... Ponder, B. A. J. (1999). The genetic epidemiology of early-onset epithelial ovarian cancer: A population-based study. American Journal of Human Genetics, 65(6), 1725-1732. DOI:10.1086/302671. Publication link: d7d9a0a1-99ab-4e22-8af1-e6f0159a4ed5 | PubMed:10577927
  • Varley, J. M., Evans, D. D. G. R., Birch, J. M., McGown, G., Thorncroft, M., James, L. A., ... Kelsey, A. (1999). Are there low-penetrance TP53 alleles? Evidence from Childhood Adrenocortical Tumours. American Journal Of Human Genetics, 65, 995-1006. . Publication link: 132a4042-0956-4ee5-93ac-56a18bd87f1b
  • Wang, Z. J., Churchman, M., Avizienyte, E., McKeown, C., Davies, S., Evans, D. G. R., ... Tomlinson, I. P. M. (1999). Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. Journal of Medical Genetics, 36(5), 365-368. . Publication link: 4f9d6a6b-acc7-4ae5-8e4f-17910bf6c093 | PubMed:10353780


  • Birch, J. M., Blair, V., Kelsey, A. M., Evans, D. G., Harris, M., Tricker, K. J., & Varley, J. M. (1998). Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene, 17(9), 1061-1068. DOI:10.1038/sj.onc.1202033. Publication link: 7bfd3754-4696-4cf5-8de8-eec5a0efd4b1 | PubMed:9764816
  • Cooper, R. A., Slevin, N. J., Johnson, R. J., & Evans, G. (1998). An unusual case of carotid body tumour. Clinical Oncology, 10(1), 62-64. DOI:10.1016/S0936-6555(98)80121-0. Publication link: 81c0f02b-2732-417e-aaf0-f306fc329c3c | PubMed:9543619
  • Evans, D. G. R., Trueman, L., Wallace, A., Collins, S., & Strachan, T. (1998). Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations. Journal of Medical Genetics, 35(6), 450-455. DOI:10.1136/jmg.35.6.450. Publication link: bf49c868-6cac-4156-8424-9fc033d97730 | PubMed:9643284
  • Evans, G., Evans, D. G. R., Wallace, A. J., Wu, C. L., Trueman, L., Ramsden, R. T., & Strachan, T. (1998). Somatic mosaicism: A common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis. American Journal of Human Genetics, 63(3), 727-736. DOI:10.1086/302004. Publication link: 290d5c80-4548-4c3a-b616-0b38811011b0 | PubMed:9718334
  • Evans, G., Varley, J. M., McGown, G., Thorncroft, M., White, G. R. M., Tricker, K. J., ... Evans, D. G. R. (1998). A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: A patient with Wilms' tumour is not a mutation carrier. British Journal of Cancer, 78(8), 1081-1083. . Publication link: bdd5c2b9-0a70-4068-a58c-921d65cac1b9 | PubMed:9792154
  • Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., & Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: Some preliminary indicators. Psycho-Oncology, 7(5), 402-412. DOI:10.1002/(SICI)1099-1611(1998090)7:5<402::AID-PON317>3.0.CO;2-X. Publication link: 37222cb8-9776-4e09-ab36-ae8ce97917db | PubMed:9809331
  • Kerr, B., Foulkes, W. D., Cade, D., Hadfield, L., Hopwood, P., Serruya, C., ... Evans, D. G. (1998). False family history of breast cancer in the family cancer clinic. European Journal of Surgical Oncology, 24(4), 275-279. . Publication link: 8eb3385b-4af0-46f5-a97d-10decefe1c4e | PubMed:9724992
  • Lalloo, F., Boggis, C. R. M., Evans, D. G. R., Shenton, A., Threlfall, A. G., & Howell, A. (1998). Screening by mammography, women with a family history of breast cancer. European Journal of Cancer, 34(6), 937-940. DOI:10.1016/S0959-8049(98)00005-7. Publication link: be0d6020-1b49-4908-a546-61c403e2bc57 | PubMed:9797712
  • Lalloo, F., Cochrane, S., Bulman, B., Varley, J., Elles, R., Howell, A., & Evans, D. G. R. (1998). An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews. Journal of Medical Genetics, 35(1), 10-12. . Publication link: d9403085-b7d7-4fc3-b39b-79292ef21258 | PubMed:9475087
  • McAllister, M. F., Evans, D. G. R., Ormiston, W., & Daly, P. (1998). Men in breast cancer families: A preliminary qualitative study of awareness and experience. Journal of Medical Genetics, 35(9), 739-744. . Publication link: 5836dfac-ce13-41a6-b942-73ac4e2b0a38 | PubMed:9733032
  • Narod, S. A., Risch, H., Moslehi, R., Dørum, A., Neuhausen, S., Olsson, H., ... Klijn, J. G. M. (1998). Oral contraceptives and the risk of hereditary ovarian cancer. New England Journal of Medicine, 339(7), 424-428. DOI:10.1056/NEJM199808133390702. Publication link: 018d9f1c-34b1-4c8f-900b-1da1c7221733 | PubMed:9700175
  • Varley, J. M., Chapman, P., McGown, G., Thorncroft, M., White, G. R. M., Greaves, M. J., ... Boyle, J. M. (1998). Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Oncogene, 16(25), 3291-3298. DOI:10.1038/sj.onc.1201878. Publication link: b85431d5-5ea1-4858-8a4d-f426382d4b77 | PubMed:9681828
  • Vasen, H. F., Haites, N. E., Evans, D. G., Steel, C. M., Møller, P., Hodgson, S., ... Caligo, M. (1998). Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.European journal of cancer (Oxford, England : 1990), 34(12). . Publication link: 851fee86-fefb-425b-b2b4-a3a4363a9d40 | PubMed:10023316
  • Wu, C. L., Thakker, N., Neary, W., Black, G., Lye, R., Ramsden, R. T., ... Evans, D. G. R. (1998). Differential diagnosis of type 2 neurofibromatosis: Molecular discrimination of NF2 and sporadic vestibular schwannomas. Journal of Medical Genetics, 35(12), 973-977. . Publication link: 1ee0a32c-a7ce-443d-8268-c6162641e667 | PubMed:9863591


  • Bijlsma, E. K., Wallace, A. J., & Evans, D. G. R. (1997). Misleading linkage results in an NF2 presymptomatic test owing to mosaicism. Journal of Medical Genetics, 34(11), 934-936. . Publication link: 4c498154-04d5-4c65-a909-f93272e4bd0a | PubMed:9391890
  • Evans, G., Armstrong, J. G., Davies, D. R., Guy, S. P., Frayling, I. M., & Evans, D. G. R. (1997). APC mutations in familial adenomatous polyposis families in the Northwest of England. Human Mutation, 10(5), 376-380. DOI:10.1002/(SICI)1098-1004(1997)10:5<376::AID-HUMU7>3.0.CO;2-D. Publication link: 68a0e4e7-84d0-4b50-933a-b89789371bc2 | PubMed:9375853
  • Evans, G., Evans, D. G. R., Mason, S., Huson, S. M., Ponder, M., Harding, A. E., & Strachan, T. (1997). Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: A clinical and molecular study. Journal of Neurology, Neurosurgery and Psychiatry, 62(4), 361-366. . Publication link: 3bdbc2d3-9147-46fc-8fce-043073f76cd1 | PubMed:9120449
  • Evans, G., Evans, D. G. R., Walsh, S., Jeacock, J., Robinson, C., Hadfield, L., ... Kingston, R. (1997). Incidence of hereditary non-polyposis colorectal cancer in a population- based study of 1137 consecutive cases of colorectal cancer. British Journal of Surgery, 84(9), 1281-1285. DOI:10.1002/bjs.1800840924. Publication link: 220cfe4a-1462-4514-80a1-3c259b915bc0 | PubMed:9313714
  • Hoban, P. R., Cowen, R. L., Mitchell, E. L. D., Evans, D. G., Kelly, M., Howard, P. J., & Heighway, J. (1997). Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour. Journal of Medical Genetics, 34(4), 343-345. . Publication link: 1eeb0e75-385f-4fa6-92e9-9e4d180d6b6b | PubMed:9138163
  • Moran, A., Collins, S., Evans, D. G. R., & Davies, R. (1997). Risk of subsequent primary cancers in patients with carcinoma of the Ampulla of Vater. British Journal of Cancer, 76(9), 1232-1233. . Publication link: 4da3ca16-1f5e-4c01-9286-c087cc01b8a7 | PubMed:9365175
  • Varley, J. M., Evans, D. G. R., & Birch, J. M. (1997). Li-Fraumeni syndrome - A molecular and clinical review. British Journal of Cancer, 76(1), 1-14. . Publication link: 20e7b976-4f4e-470b-a52f-1af852a8aa76 | PubMed:9218725
  • Varley, J. M., McGown, G., Thorncroft, M., Santibanez-Koref, M. F., Kelsey, A. M., Tricker, K. J., ... Birch, J. M. (1997). Germ-line mutations of TP53 in li-fraumeni families: An extended study of 39 families. Cancer Research, 57(15), 3245-3252. . Publication link: 155fa156-2975-4ca7-9964-5992f0751750 | PubMed:9242456
  • Varley, J. M., Thorncroft, M., McGown, G., Appleby, J., Kelsey, A. M., Tricker, K. J., ... Birch, J. M. (1997). A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Oncogene, 14(7), 865-871. DOI:10.1038/sj.onc.1201041. Publication link: 1d9bf434-6524-44a6-9179-5ab2054c7f51 | PubMed:9047394


  • Brassett, C., Joyce, J. A., Froggatt, N. J., Williams, G., Furniss, D., Walsh, S., ... Maher, E. R. (1996). Microsatellite instability in early onset and familial colorectal cancer. Journal of Medical Genetics, 33(12), 981-985. . Publication link: 96735702-c8c8-4e3a-8c21-3b4e568f6759 | PubMed:9004127
  • Evans, G., Colley, A., Donnai, D., & Evans, D. G. R. (1996). Neurofibromatosis/Noonan phenotype: A variable feature of type 1 neurofibromatosis. Clinical Genetics, 49(2), 59-64. . Publication link: e60d307a-bd4e-4edc-aa22-40d30c47fcc7 | PubMed:8740913
  • Froggatt, N. J., Brassett, C., Koch, D. J., Evans, D. G. R., Hodgson, S. V., Ponder, B. A. J., & Maher, E. R. (1996). Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. Journal of Medical Genetics, 33(9), 726-730. . Publication link: 8ba203a2-a2fc-46b4-a714-a0c42be82424 | PubMed:8880570
  • Maddock, I. R., Moran, A., Maher, E. R., Teare, M. D., Norman, A., Payne, S. J., ... Evans, D. G. R. (1996). A genetic register for von Hippel-Lindau disease. Journal of Medical Genetics, 33(2), 120-127. . Publication link: b29e57b2-a1a2-48a6-baf4-5aa9b12ff89f | PubMed:8929948
  • Neary, W. J., Newton, V. E., Laoide-Kemp, S. N., Ramsden, R. T., Griffith, G., Evans, D. G., ... Strachan, T. (1996). A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas. The Journal of laryngology and otology, 110(7), 634-640. . Publication link: 9dda2849-319e-4c44-8d1d-6e78e59e4308 | PubMed:8759535
  • Scott, R. J., Froggatt, N. J., Trembath, R. C., Evans, D. G. R., Hodgson, S. V., & Maher, E. R. (1996). Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation. Human Molecular Genetics, 5(12), 1921-1924. . Publication link: 0ba0da0a-3127-4d74-9a6d-3f7277c4d495 | PubMed:8968744
  • Thakker, N. S., Evans, D. G. R., Horner, K., Davies, D. R., Armstrong, J., Guy, S., ... Sloan, P. (1996). Florid oral manifestations in an atypical familial adenomatous polyposis family with late presentation of colorectal polyps. Journal of Oral Pathology and Medicine, 25(8), 459-462. . Publication link: ecdc6de6-b546-4c8c-ac47-7812d45d7869 | PubMed:8930826
  • Varley, J. M., McGown, G., Thorncroft, M., Cochrane, S., Morrison, P., Woll, P., ... Evans, D. G. (1996). A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome.Oncogene, 12(11). . Publication link: 58675d67-defb-4a62-8e85-dc7695007e60 | PubMed:8649785
  • Varley, J. M., Thorncroft, M., McGown, G., Tricker, K., Birch, J. M., & Evans, D. G. R. (1996). A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni- like syndrome, and LOH in a benign lesion from a mutation carrier. Cancer Genetics and Cytogenetics, 90(1), 14-16. DOI:10.1016/0165-4608(96)00059-3. Publication link: 80d425f3-e384-4ead-b81c-1e2236880213 | PubMed:8780740


  • Bourn, D., Evans, G., Mason, S., Tekes, S., Trueman, L., & Strachan, T. (1995). Eleven novel mutations in the NF2 tumour suppressor gene. Human Genetics, 95(5), 572-574. DOI:10.1007/BF00223872. Publication link: c890f672-a136-4ea3-a62a-3771f0846d55 | PubMed:7759081
  • Evans, D. G. R., Bourn, D., Wallace, A., Ramsden, R. T., Mitchell, J. D., & Strachan, T. (1995). Diagnostic issues in a family with late onset type 2 neurofibromatosis. Journal of Medical Genetics, 32(6), 470-474. . Publication link: 533a3e85-52f5-45d4-ba53-e5180390010b | PubMed:7666400
  • Evans, D. G., Blair, V., Strachan, T., Lye, R. H., & Ramsden, R. T. (1995). Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females.The Journal of laryngology and otology, 109(9). . Publication link: a86fb7cf-be1e-4153-95a9-c14d7dea6e2c | PubMed:7494114
  • Froggatt, N. J., Koch, J., Davies, R., Evans, D. G. R., Clamp, A., Quarrell, O. W. J., ... Maher, E. R. (1995). Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome. Journal of Medical Genetics, 32(5), 352-357. . Publication link: 0e985bee-1f91-4ed1-b904-1ab8a023bbfb | PubMed:7616541
  • Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., ... Ponder, B. A. J. (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genetics, 11(4), 428-433. DOI:10.1038/ng1295-428. Publication link: 00df0efe-a075-41be-8cd8-c26c273ad45c | PubMed:7493024
  • Gokhale, D. A., Evans, D. G., Crowther, D., Woll, P., Watson, C. J., Dearden, S. P., ... Taylor, G. M. (1995). Molecular genetic analysis of a family with a history of Hodgkin's disease and dyschondrosteosis.Leukemia, 9(5). . Publication link: 795dda63-b535-45a7-9ba0-cdc6f7fb2692 | PubMed:7769845
  • Hodgson, S. V., Bishop, D. T., Dunlop, M. G., Evans, D. G., & Northover, J. M. (1995). Suggested screening guidelines for familial colorectal cancer.Journal of Medical Screening, 2(1), 45-51. . Publication link: 2c755917-73e6-438c-9e9d-c2895acddac0 | PubMed:7497146
  • Joyce, J. A., Froggatt, N. J., Davies, R., Evans, D. G. R., Trembath, R., Barton, D. E., & Maher, E. R. (1995). Molecular genetic analysis of exons 1 to 6 of the APC gene in non-polyposis familial colorectal cancer. Clinical Genetics, 48(6), 299-303. . Publication link: 9d7993a4-9dc1-45e2-9c4b-46fa28f0ee53 | PubMed:8835324
  • McGaughran, J. M., Ward, H. B., & Evans, D. G. R. (1995). WAGR syndrome and multiple exostoses in a patient with del (11) (p11.2p14.2). Journal of Medical Genetics, 32(10), 823-824. DOI:10.1136/jmg.32.10.823. Publication link: b46fd76b-015d-49ba-a4aa-0bf5b20e7556 | PubMed:8558565
  • Thakker, N., Davies, R., Horner, K., Armstrong, J., Clancy, T., Guy, S., ... Evans, G. (1995). The dental phenotype in familial adenomatous polyposis: Diagnostic application of a weighted scoring system for changes on dental panoramic radiographs. Journal of Medical Genetics, 32(6), 458-464. . Publication link: 1fa1bdfa-238f-4c77-8552-7543346608f0 | PubMed:7666398
  • Varley, J. M., McGown, G., Thorncroft, M., Tricker, K. J., Teare, M. D., Santibanez-Koref, M. F., ... Evans, D. G. R. (1995). An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. Journal of Medical Genetics, 32(12), 942-945. DOI:10.1136/jmg.32.12.942. Publication link: a363cf49-21be-460b-b3f9-47a7c4c870c2 | PubMed:8825920


  • Bourn, D., Carter, S. A., Evans, D. G. R., Goodship, J., Coakham, H., & Strachan, T. (1994). A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. American Journal of Human Genetics, 55(1), 69-73. . Publication link: a75bc85c-99d1-4b6c-a281-5e07f2099701 | PubMed:8023853
  • Evans, D. G. R., Blair, V., Greenhalgh, R., Hopwood, P., & Howell, A. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. British Journal of Cancer, 70(5), 934-938. . Publication link: b1ef554d-c80b-4d5c-8e50-4d7d49ee80c9 | PubMed:7947100
  • Evans, D. G. R., Rees, H. C., Spreadborough, A., Campbell, D. J., Gau, G. S., Pickering, E., ... Clayton-Smith, J. (1994). Radial ray defects, renal ectopia, duodenal atresia and hydrocephalus: The extended spectrum for Fanconi anaemia. Clinical Dysmorphology, 3(3), 200-206. . Publication link: e5232989-c6e3-415e-9247-968b3cb69223 | PubMed:7981854
  • Evans, D. G., Fentiman, I. S., McPherson, K., Asbury, D., Ponder, B. A., & Howell, A. (1994). Familial breast cancer.BMJ (Clinical research ed.), 308(6922). . Publication link: 1a6e41f5-2210-4a3c-a204-a461947145c8 | PubMed:8312772
  • Richards, F. M., Crossey, P. A., Phipps, M. E., Foster, K., Latif, F., Evans, G., ... Maher, E. R. (1994). Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Human Molecular Genetics, 3(4), 595-598. . Publication link: 869a3ca9-3521-4dde-aec7-c94d6c4be8d7 | PubMed:8069305
  • Rubinsztein, D. C., Hanlon, C. S., Irving, R. M., Goodburn, S., Evans, D. G., Kellar-Wood, H., ... Harding, A. E. (1994). Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease.Molecular and Cellular Probes, 8(6). . Publication link: 9b26c2ed-9c70-499a-aee3-f78db0a31c20 | PubMed:7700274
  • Ruttledge, M. H., Xie, Y. G., Han, F. Y., Giovannini, M., Janson, M., Fransson, I., ... Dumanski, J. P. (1994). Physical mapping of the NF2/meningioma region on human chromosome 22q12. Genomics, 19(1), 52-59. DOI:10.1006/geno.1994.1012. Publication link: ebe28622-f075-41ca-81b2-7a67ce19f7e4 | PubMed:8188242
  • Steichen-Gersdorf, E., Gallion, H. H., Ford, D., Girodet, C., Easton, D. F., DiCioccio, R. A., ... Mazoyer, S. (1994). Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.American Journal of Human Genetics, 55(5). . Publication link: af0a4870-6d6f-41e6-b5ea-cb5b92e8ac61 | PubMed:7977348


  • Evans, D. G. R., Burnell, L. D., Hopwood, P., & Howell, A. (1993). Perception of risk in women with a family history of breast cancer. British Journal of Cancer, 67(3), 612-614. . Publication link: 9c8df5bf-ef57-481d-8102-0f94d3f70927 | PubMed:8439512
  • Evans, D. G. R., Guy, S. P., Thakker, N., Armstrong, J. G., Dodd, C., Davies, D. R., ... Harris, R. (1993). Non-penetrance and late appearance of polyps in families with familial adenomatous polyposis. Gut, 34(10), 1389-1393. . Publication link: da730a5c-ed2d-4e08-bb06-dc50048e6f85 | PubMed:8244107
  • Evans, D. G. R., Ramsden, R., Huson, S. M., Harris, R., Lye, R., & King, T. T. (1993). Type 2 neurofibromatosis: The need for supraregional care?. The Journal of laryngology and otology, 107(5), 401-406. . Publication link: 27b73021-bdc4-4176-8729-057be3aa3866 | PubMed:8326218
  • Evans, G., Burnell, L., Campbell, R., Gattamaneni, H. R., & Birch, J. (1993). Congenital anomalies and genetic syndromes in 173 cases of medulloblastoma. Medical and Pediatric Oncology, 21(6), 433-434. . Publication link: ff050daf-e732-4106-939a-a737c9282bd4 | PubMed:8515724
  • Evans, G., Evans, D. G. R., Ladusans, E. J., Rimmer, S., Burnell, L. D., Thakker, N., & Farndon, P. A. (1993). Complications of the naevoid basal cell carcinoma syndrome: Results of a population based study. Journal of Medical Genetics, 30(6), 460-464. . Publication link: 01d4469f-87a0-4f6a-949f-64d72a240d90 | PubMed:8326488
  • Neary, W. J., Newton, V. E., Vidler, M., Ramsden, R. T., Lye, R. H., Dutton, J. E. M., ... Strachan, T. (1993). A clinical, genetic and audiological study of patients and families with bilateral acoustic neurofibromatosis. The Journal of laryngology and otology, 107(1), 6-11. . Publication link: c7589733-3049-4a9f-be7c-d623a1ec4595 | PubMed:8445320
  • Shah, S., Evans, D. G. R., Blair, V., Burnell, L. D., & Birch, J. M. (1993). Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry. Cancer, 72(3), 819-827. . Publication link: 7b1804f5-aa83-468b-bf17-c51526b17733 | PubMed:8334636
  • Teare, M. D., Santibáñez-Koref, M. F., Wallace, S. A., White, G. R. M., Evans, D. G. R., Burnell, L. D., ... Birch, J. M. (1993). A linkage study in seven breast cancer families. American Journal of Human Genetics, 52(4), 786-788. . Publication link: c95a3cf6-f24d-4bf3-b473-5c72e412b7ba | PubMed:8460644
  • Watson, C. J., Gaunt, L., Evans, G., Patel, K., Harris, R., & Strachan, T. (1993). A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus.Human molecular genetics, 2(6). . Publication link: 93634f7a-4011-4e74-a85e-7ce9809652ad | PubMed:8102569


  • Bobrow, M., Harper, P., Harris, J., Evans, G., & Hunt, A. (1992). Seminar on ethical issues arising from molecular studies in human genetic disease: held under the auspices of the UK Cancer Family Study Group in Manchester--21st May 1992.Disease markers, 10(4). . Publication link: b37211ef-5c45-4ba1-9902-f7e77b364c0c | PubMed:1304436
  • Evans, D. G. R., Huson, S. M., Donnai, D., Neary, W., Blair, V., Newton, V., & Harris, R. (1992). A clinical study of type 2 neurofibromatosis. Quarterly Journal of Medicine, 84(304), 603-618. . Publication link: 36ce46e8-74d5-4bf5-9d5f-06bf7b0071af | PubMed:1484939
  • Evans, D. G., Ribiero, G., Warrell, D., & Donnai, D. (1992). Ovarian cancer family and prophylactic choices.Journal of medical genetics, 29(6). . Publication link: b2f0eed4-d2cd-419e-8da1-a829d43aee4b | PubMed:1320125
  • Evans, G. (1992). Ethical issues: the geneticist's view point.Disease markers, 10(4). . Publication link: e3293b6b-9e53-4b33-9189-0cedd9fef806 | PubMed:1338981
  • Evans, G., Evans, D. G. R., Huson, S. M., Donnai, D., Neary, W., Blair, V., ... Harris, R. (1992). A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. Journal of Medical Genetics, 29(12), 841-846. . Publication link: c1dc6ec2-6712-4eb9-8187-fce4ce0840cb | PubMed:1479598
  • Evans, G., Evans, D. G. R., Huson, S. M., Donnai, D., Neary, W., Blair, V., ... Harris, R. (1992). A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. Journal of Medical Genetics, 29(12), 847-852. . Publication link: 172d8584-2cba-4a74-a1cc-c5243c423cec | PubMed:1479599
  • Farndon, P. A., Del Mastro, R. G., Evans, D. G. R., & Kilpatrick, M. W. (1992). Location of gene for Gorlin syndrome. The Lancet, 339(8793), 581-582. . Publication link: 17c396b1-de79-4d1a-bff5-40f377969368 | PubMed:1347096
  • Smith, S. A., Easton, D. F., Evans, D. G. R., & Ponder, B. A. J. (1992). Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genetics, 2(2), 128-131. DOI:10.1038/ng1092-128. Publication link: 24959a57-49a8-4d60-be19-98687a4548b3 | PubMed:1303261


  • Evans, D. G. R. (1991). Dominantly inherited microcephaly, hypotelorism and normal intelligence. Clinical Genetics, 39(3), 178-180. . Publication link: 97ddc348-d2ef-4760-8cfc-4441147766c4 | PubMed:2036738
  • Evans, D. G. R., & Lyon, A. J. (1991). Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion. European Journal of Pediatrics, 150(11), 780-781. DOI:10.1007/BF02026710. Publication link: 9cde6575-5cb1-4e64-acd6-d767ca0cc493 | PubMed:1659984
  • Evans, D. G. R., Birch, J. M., & Orton, C. I. (1991). Brain tumours and the occurrence of severe invasive basal cell carcinoma in first degree relatives with gorlin syndrome. British Journal of Neurosurgery, 5(6), 643-646. DOI:10.3109/02688699109002890. Publication link: 8873d747-a5f2-4538-b49f-84594ee87e72 | PubMed:1772613
  • Evans, D. G. R., Farndon, L. A., Burnell, L. D., Rao Gattamaneni, H., & Birch, J. M. (1991). The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. British Journal of Cancer, 64(5), 959-961. . Publication link: 755683f0-12ee-4ac4-80f6-622072ffe80b | PubMed:1931625
  • Evans, D. G. R., Lonsdale, R. N., & Patton, M. A. (1991). Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome. Clinical Genetics, 39(3), 228-232. . Publication link: dff12354-2b64-41dc-a62f-a68429ccefcc | PubMed:2036745
  • Evans, D. G. R., Thakker, Y., & Donnai, D. (1991). Heredity and dysmorphic syndromes in congenital limb deficiencies. Prosthetics and Orthotics International, 15(2), 70-77. DOI:10.3109/03093649109164636. Publication link: 031e45f1-773f-46f6-92f5-92acd6ea6f1a | PubMed:1923725
  • Evans, D. G., Robertson, D., & Bennett, J. D. (1991). Space infections of the head and neck--the "new" clinical picture.Journal of the Royal Army Medical Corps, 137(1), 35-37. . Publication link: 74256ae1-352f-4cb7-b2f0-4fda35b3a37b | PubMed:2023168
  • Evans, D. G., Sims, D. G., & Donnai, D. (1991). Family implications of neonatal Gorlin's syndrome.Archives of Disease in Childhood, 66(10 Spec No). . Publication link: 61575831-8f50-4241-9c78-6c4c0697a762 | PubMed:1750770


  • Evans, G., Evans, D. G. R., Evans, I. D., Donnai, D., & Lindenbaum, R. H. (1990). Ankyloblepharon filiforme adnatum in trisomy 18 Edwards syndrome. Journal of Medical Genetics, 27(11), 720-721. . Publication link: 85a1cb54-4112-4a5d-af56-f56ebb85c38a | PubMed:2277391